ABSTRACT
Sindbis virus (SINV), a widely distributed alphavirus, is both a foundational model for viral replication studies and an underrecognized human pathogen. Despite its typically mild presentation, SINV can lead to prolonged joint pain and, in rare cases, neurological complications. This review explores SINV’s molecular biology and clinical manifestations, particularly its role in causing Sindbis Fever – a self-limiting but potentially chronic arthritic disease. Molecular insights reveal mechanisms of immune evasion, neurovirulence, and persistent infection, highlighting SINV’s potential for broader public health impact, especially under changing climatic conditions. This review also identifies key virulence determinants and discusses the virus’s utility as a model for studying alphaviral encephalitis. Continued research is essential to better understand SINV pathogenesis and to prepare for potential outbreaks.
KEYWORDS: Sindbis virus, viral arthritis, alphavirus, arbovirus, neurovirulence, immune evasion
Introduction
Sindbis virus (SINV) is an enveloped single-stranded positive-sense RNA virus belonging to the family Togaviridae [1,2]. Like many other members of the genus Alphavirus, SINV is maintained during the enzootic cycle via cyclic transmission between avian vertebrate hosts and vector competent mosquitoes. Epizootic spill-over occurs when SINV-infected mosquitoes feed upon humans or equids leading to their infection. Unlike the avian hosts of the enzootic cycle, both humans and equids are presumed to be dead-end hosts regarding transmission, as SINV fails to reach a high viremia precluding the infection of the blood-feeding mosquito [3–5]. In humans, SINV is the causative agent of an infectious musculoskeletal disease known as Sindbis Fever, which is also referred to as Pogosta Disease in Finland [6], Ockelbo Disease in Sweden [7,8], and Karelian Fever in Russia [6,9]. SINV is best known as the model or archetypic species of the genus alphavirus due to the extensive use of SINV in the pioneering/foundational work examining alphaviral molecular biology and replication [1,2]. On the basis of relative clinical severity to other alphaviruses, SINV is often overlooked as a pathogen. Nevertheless, SINV remains a human pathogen of significant concern due to its capacity to cause severe disease in otherwise healthy individuals during regular seasonal outbreaks in endemic areas and large-scale regional outbreaks [3,7,9–32].
SINV was first isolated from Culex mosquitoes in the community of Sindbis in the Nile River delta near Cairo, Egypt in 1952 [33]. The first human cases of SINV Fever were described nearly a decade later in Central and Southern Africa, notably in Uganda in 1961 and later in South Africa in 1963 [10,11]. It was during these outbreaks of mosquito-borne febrile illness that SINV was identified as a causative agent of an infectious rash-arthritis syndrome.
Phylogenetic analyses of SINV and SINV-like viruses led to the establishment of at least six genotypes which correlate spatially with bird migratory patterns [34], with Sindbis virus strain AR339 being the type species of Genotype I (referred hereto forth as G1). More recently, the viruses belonging to G5 have been demarcated as a separate species from SINV, with Whataroa virus (WHAV) as the type species [35,36]. Indeed, despite similarities across the remaining SINV genotypes, mounting evidence strongly supports further demarcation of the other genotypes as distinct viral species from those of G1. The species demarcation criteria for the Togavirus family set forth by the International Committee on the Taxonomy of Viruses (ICTV) currently includes i) nucleotide and amino acid sequence divergence, ii) antigenic characteristics, iii) vector association, iv) host association, v) disease association (pathogenesis), and vi) ecological characteristics [36]. Generally, a 10% divergence in amino acid sequence is considered an indicator of potential speciation, but the conservative demarcation of new species requires a combination of demarcating factors due to some members of the family exhibiting a high degree of sequence variation, such as that observed with VEEV [36].
Recent efforts examining SINV genotype diversity have utilized comparative phylogenetics to examine the relationships and distances between the SIVN genotypes and provided robust rationale for the demarcation of the SINV genotypes as unique species [37]. Considering the sequence diversity thresholds set forth by the ICTV, nearly all of the SINV genotypes meet the criteria for demarcation as G2, G3, and G6 all differ from G1 by at least 23% nucleotide divergence and 10.28% amino acid divergence [37]. Sequence comparisons also strongly infer that the G2 and G3 genotypes are highly interrelated and should be unified under a single genotype, with Argyle virus (ARGV) as the representative member (as proposed by Michie et al. [37]. Notably, only G4 fails to meet the conservative amino acid demarcation requirement relative to G1, as the range of amino acid divergence is 7.40 to 8.89 percent [37].
Beyond sequence identity, divergent antigenic characteristics is a property by which a need for demarcation may be indicated. Comparative analyses of sera from G1 and G5 infections revealed antigenic distinction between the two genotypes, which together with amino acid divergence, was used as evidence supporting the demarcation of WHAV (G5) as a distinct alphavirus species [38]. Similarly, a study examining the capacity of anti-AR339 (G1) monoclonal antibodies to recognize the viral glycoproteins of G2 and G3 viruses revealed antigenic distinctiveness amongst the three genotypes in question [39]. Coupled with the sequence divergence noted in the paragraph above, these antigenic differences support the demarcation of G2 and G3 as a unified unique species, with ARGV as the type species [37]. Members of G4, namely Kyzylagach virus and XJ-160 viruses, have shown antigenic similarities to G1 members in that neutralizing G1 antibodies can reduce the infectivity of G4 viruses; however, the effects are not reciprocal, as in antibodies neutralizing G4 viruses poorly neutralize G1 viruses, indicating that there is antigenic divergence between the two genotypes [40,41].
The use of vectorial and host association as demarcating criteria by which the individual SINV genotypes may be deemed unique species is difficult to effectively parse. This is primarily due to the members of G1 (and all SINV-like genotypes) exhibiting broad host tropism. Thus, in the absence of exhaustive comparative discriminative analyses of vector competence and host range for each of the SINV-like genotypes in a controlled laboratory setting, it is difficult to build arguments for or against demarcation based on vector and host association. Despite this complexity there are notable instances where arguments for demarcation may be made based on reservoir host species, such as the observation that herons are the probable reservoir host for G4 viruses [42], whereas grouse and Passeriformes are implicated for G1 viruses in Northern Europe [17,43–45].
Disease association is a more straightforward criterion that supports the demarcation of G1 from all other genotypes, as only members of G1 are associated with human disease [4,18,21,25,26,46]. While serological evidence supports the presence of human infections for other genotypes, no clinical illnesses have been reported in areas with endemic non-G1 genotypes [35,41]. Hence, one of the conditions set forth by the ICTV for demarcation is universally achieved for all SINV-like genotypes.
Finally, ecological characteristics serve to both separate and confound the demarcation of the individual genotypes. Due to migratory patterns of the probable avian hosts many of the genotypes exhibit broad regional distribution which may overlap, with G1 common to Europe, Africa, and the Middle East; G2 and G6 from Australia; G3 from Southeast Asia; G4 from Asia and the Middle East; and G5 (WHAV) from New Zealand [34]. Nonetheless, in specific instances ecological characteristics may be used as an effective demarcation criterion, as G6 is highly geographically restricted to the south-west region of Western Australia, leading Michie et al. 2023, to promote G6 as a distinct species with Thomson’s Lake virus (THLV) as the type species [37].
Altogether, the satisfaction of multiple demarcation criteria for G2/3 (ARGV) and G6 (THLV) indicates that they are not simply SINV-like viruses, but rather that they are unique species distinct from G1 (SINV), as was previously established for G5 (WHAV). While the overall precise nature of the relationship between G1 and G4 is less defined, we posit that there is sufficient evidence to propose that demarcation is warranted based on borderline sequence identity, antigenic distinction, probable differences in avian reservoir hosts, and pathogenic differences. Accordingly, as there is sufficient evidence supporting complete demarcation, this review will focus on G1 viruses, or Sindbis virus proper, with AR339 as the representative type strain. Shortly after the discovery of SINV human cases were also reported in Northern Europe in 1967 [14–16,20], and more recently, SINV has been reported to have been detected in mosquito populations in southwestern Spain [32], suggesting ongoing expansion of the geographic range. As shown in Figure 1, and further detailed in Supplemental Data Table 1, SINV exhibits a wide geographic range with infections reported across the European and African continents and, and the Middle East [35]. The geographic range of SINV is predominantly a function of the presence and relative abundance of vector competent mosquito species, typically Culex spp., and suitable avian reservoir hosts, such as grouse and passeriformes [13,26,45,47,48]. Accordingly, it is unsurprising that the global distribution of SINV follows migratory routes, and endemic regions are commonly associated with wetland environments, humid forestlands, or settings where stagnant water is likely to form during warm summers [13,17,44,45,47,49–52].
Figure 1.

Sindbis virus is a widely distributed arthropod-borne pathogen.
A map identifying specific countries reporting SINV infections of Humans (Red), Mammals (Magenta), Avians (Blue), and Mosquitoes (Yellow). Countries where SINV has been detected in humans may be reasonably assumed to also have infections, recognized or unrecognized, in avian and mosquito populations. Countries where SINV has been detected in one or more of the nonhuman categories listed above may be identified by their color combination, as defined in the lower left corner of the figure. Countries with a gray coloration have had reports of SINV detection but the literature is unclear as to the precise host species. The entire country is highlighted even if SINV is regionally limited, with the exception of Russia as SINV has only been detected in the region of Karelia, and China where SINV (genotype 1) has only been reported in Yunan Province. Significant outbreaks of SINV in human populations are indicated by black text indicating the country affected and year of occurrence. North and South America are not included in the figure as there have been no reports of detection in either animals or humans despite widespread distribution of Culex spp. mosquitoes. Specific references for the map may be found detailed in Supplemental Data Table 1.
Perplexingly, local transmission of SINV (or a SINV-like virus), has not been detected on the North or South American continents despite all required environmental factors being present. The fact that Western Equine Encephalitis (WEEV) is a recombinant of Eastern Equine Encephalitis virus (EEEV) and SINV suggests that SINV was at one time present (estimated to be approximately 1300 to 1900 years ago) in close proximity to EEEV (which is exclusive to the American continents) [53].
Despite a widespread geographic range, most reported human cases are from Northern Europe where the virus is endemic, and large outbreaks occur intermittently at an almost cyclical rate of several years [18,47]. This increased burden may also be due to generalized SINV-awareness, as notably, SINV is a reportable/notifiable disease in Finland, where active surveillance systems are in place [54,55]. It is from outbreaks in these regions that the ecology and epidemiology of SINV is best understood. Due to this fact, and the often-mild self-limiting nature of infection, it is difficult to accurately estimate the annual burden of SINV disease on a global basis. In endemic areas general seroprevalence rates range from 3 to 10%, with the likelihood of seroconversion increasing with age [23,55–57]. During SINV outbreaks the observed incidence rates vary but may achieve a notably high rate for a mosquito-borne viral infection, as illustrated by the 2021 outbreak in Finland where peak incidence rates were in excess of 40 cases per 100k population [54]. Factors driving SINV outbreaks largely include those that impact the vector mosquito populations such as rainfall, temperature, and other climate-related phenomena, which have been demonstrated to impact a number of mosquito-borne pathogens [58–60].
Sindbis Fever, Sindbis virus as a human pathogen
As an arbovirus, SINV infection and disease begins with an infected mosquito depositing viral particles into the vertebrate host through the injection of virus-containing mosquito saliva while feeding. The viral particles, aided by the anti-inflammatory and vasodilatory nature of components of the mosquito saliva, engage with the host cells in the dermis to initiate infection [61]. In this niche the virus replicates locally in keratinocytes and dermal fibroblasts until entering the bloodstream [62,63]. The resulting viremia leads to the dissemination of the virus to other tissues in the host including muscle cells, tendons, joint cells (especially synovial fibroblasts), macrophages, and cells of the central nervous system [62–65]. The combined efforts of the innate and adaptive immune system ultimately clear the virus from the host; however, persistent infection has been reported during SINV infection in humans and mouse models of infection [66,67].
The ratio of subclinical to clinically diagnosed infections is estimated to range between 40 and 20:1, with underdiagnosis highly likely [21,22]. SINV infection and disease are typically thought of as self-limiting with the acute phase of infection lasting between 1 and 3 weeks; however, severe symptoms may occur in otherwise healthy individuals [4,46]. The main clinical symptoms of acute SINV infection (as depicted in Figure 2A) are mild fever accompanied by a maculopapular rash with itchy exanthema disseminated over the trunk and limbs [3,46,68,69], headache, malaise, muscle pain, and mild to severe arthritis particularly in the wrists, hips, knees and ankles [4,19,23,46]. The inflammation and joint pain associated with SINV infection appears to be exacerbated by prior joint injury or underlying arthritic conditions [70]. Most individuals suffering from clinical SINV infection recover within weeks or months, yet a substantial proportion of patients, up to 50% report experiencing chronic arthralgia for 6–8 months after infection, of which some may experience persistent joint pain and inflammation for years [66,71–73]. The persistent infection of macrophages has been observed in patients with long-term alphavirus-induced arthritis and the presence of these macrophages appears to correlate with clinical severity [74–76]. To date, despite several reports of otherwise severe disease, including a single report of recurrent hemorrhagic skin lesions [77], there have been no reported human fatalities involving SINV as the cause of death.
Figure 2.

Sindbis virus disease in humans and mouse models of infection.
(A) A representation of clinical signs of SINV-induced illness in humans, with the red text representing the acute symptoms of SINV Fever. Long-term or latent impacts of SINV infection are noted in blue text. (B) For rodent models of experimental SINV infection the impacts of SINV infection are noted. For human infections the severity and commonality of occurrence is noted below in parentheses, and for mouse infections the severity and time to occurrence post-experimental infection is noted.
SINV has been investigated from a public health standpoint to determine whether or not SINV infection correlates with the later development of Rheumatoid Arthritis (RA) as the inflammatory nature of the two diseases are highly similar. Nevertheless, prior SINV infection was not found to be a risk factor for the development of RA; but, curiously, SINV infection does lead to enhanced levels of autoreactive antibodies in certain individuals particularly antinuclear antibodies, antimitochondrial antibodies, and rheumatoid factor antibodies [78]. This suggests that SINV infection may exacerbate autoimmune diseases but does not directly lead to the development of autoimmunity. In line with these observations are the findings that SINV infection does not directly lead to the development of citrulline-positive antibodies [78]. While no linkage between SINV infection and autoimmunity has been established, SINV infection, as determined by seropositivity, was associated with prior cerebral infarction or stroke by approximately 4-fold [55].
Despite SINV being ordinarily associated with musculoskeletal disease in humans, studies examining hospitalized patients with acute fever diseases of unknown causes in South Africa have indicated that SINV infection can cause meningoencephalitis and other neurological symptoms in otherwise healthy persons [79]. A similar observation was made, albeit with less frequency, during an outbreak of SINV in Northern Europe [73]. While certainly overshadowed by the neurological diseases associated with New World alphaviruses [80]; the observation that SINV infection can cause neurological disease in humans is predictable as animal models of SINV infection often demonstrate neurotropic infections. As described in more detail later, infections of other mammals including mice and horses may ultimately conclude in severe neuropathogenesis and death. Regardless, the neurological manifestations of SINV in humans tend to be mild (and commonly include confusion and weakness) and full recovery is the typical outcome [73]. The full extent to which symptomatic SINV infection contributes, and whether asymptomatic neurotropic SINV infection contributes to the later development of neuroinflammatory diseases, is unknown at this time.
The molecular basis of Sindbis Fever in humans
Frustratingly, the pathogenesis observed during SINV infection of rodents poorly mimics the symptoms observed in humans, as arthritogenic disease is absent in mouse models of infection. While viral replication can be readily detected in joint and muscle tissues of experimentally infected mice, the overall inflammatory manifestation within the joint spaces is limited [65]. Accordingly, much of what is known, or presumed to be true, regarding alphaviral-induced arthritis stems from investigations of alphaviruses with far more robust mouse models of musculoskeletal disease such as Ross River virus (RRV) and CHIKV, or a limited number of clinical studies involving human cases of SINV Fever or primary cells taken from human donors. These generalities are described in more detail below, with specific instances where observations have been confirmed in SINV are noted.
Alphaviral-induced arthritis is the result of the immune response elicited by the production of pro-inflammatory cytokines and chemokines which promote the pathophysiological inflammatory state [65,81–83]. This response is orchestrated by cells in the synovial joints, such as the type A and type B synoviocytes (which are macrophage-like and fibroblast-like, respectively) and infiltrating immune cells responding to the infection [65,82–86]. The underlying inflammatory response induced by alphaviruses strongly resembles that observed during RA [87]; however, as noted earlier the autoimmune component is lacking [78,88]. In general, from studies using human patient data and animal models of alphaviral arthritis, acute alphaviral-induced arthritis is hallmarked by increased levels of IFNα/β, IFNγ, TNFα, IL-6, IL-1, IP-10, IL-12, IL-15 and CXCL9MCP-1 (CCL2), and MIF-I [74,83,87,89–98]. While not as exhaustively studied, SINV infections of primary human macrophages have been shown to stimulate similar cytokine expression profiles [99]. Many of the pro-inflammatory cytokines observed during the acute phase of infection are also observed in patients with chronic alphaviral-induced arthritis, in particular IL-1, IL-6 and GM-CSF and levels of these cytokines correlate with disease severity and are considered a strong prognosticator of long-term chronic arthritis [96–98]. Altogether the cytokines and chemokines produced during alphaviral infection serve to contribute to inflammation in the synovial space and eventually erosive bone damage/loss [100].
At the cellular level, macrophages which are amongst, if not the major, monocytic infiltrates into the synovial space are understood to play a central role in the development and long-term maintenance of alphaviral-induced arthritis [74,81,92,94,99]. Exposure of human macrophage tissue culture cell lines and primary human monocytes to SINV infection in vitro results in a robust pro-inflammatory response marked by increased levels of MIF, TNFα, IL-1, and IL-6 expression [99]. Again, akin to the pathophysiology of RA, this cytokine response leads to joint injury through the induction of matrix metalloproteinases, as MMP1 and MMP3 are strongly expressed in a MIF-dependent manner during active SINV infection [99]. The persistent infection of macrophages has been reported for both RRV and CHIKV and has been postulated as a primary driver of chronic alphavirus-induced arthritis in human and animal models of disease [74–76,92]. Whether a similar phenomenon occurs during SINV infection is unknown, but numerous similarities between the pathological etiologies indicate a strong likelihood of persistent infection.
Sindbis as a model pathogen for alphavirus-induced encephalitis
Despite being a poor model of alphavirus-induced arthritis, SINV is an excellent model of neurotropic infection and alphaviral-induced encephalitis and has been used as a surrogate model for the encephalitic alphaviruses, namely- Eastern Equine Encephalitis virus (EEEV), Western Equine Encephalitis virus (WEEV), and Venezuelan Equine Encephalitis virus (VEEV). Despite age and mouse genotypic dependencies, the steady predictable pattern of infection and disease observed during SINV infections of mice have enabled complex dissections of the underlying pathogenic mechanisms and inflammatory responses seen during alphaviral-induced encephalitis.
Precisely why SINV infections of humans and mice results in such disparate pathological outcomes is not known and remains an area in need of further assessment. Potential mechanisms include tissue tropism differences between the hosts as determined by susceptibility and permissivity differences in the central nervous system tissues. Nonetheless, SINV has been demonstrated to infect a number of cell types found in the human central nervous system [101–103]. As such, differences in tropism are likely to be a minor contributing factor and not wholly explain the pathological differences. Alternatively, differences in the overall robustness of the host immune response to infection may limit or preclude severe neurological disease in humans. It should be noted that SINV disease in mice is largely dependent on viral strain, mouse strain, and age. Prior studies examining SINV infections of BALB/cBy and C57BL/6 mouse strains revealed the presence of resistance loci on Chromosome 2 of BALB/cBy [104,105]. This Quantitative Trait Locus (QTL), termed Nsv1, is spatially close to a number of genes involved in the innate immune response to viral infection, including IL1rn and several IL-1 cytokine family members, Psd4, and Pax8. Nonetheless, the precise mechanistic underpinnings of the Nsv1 QTL have not been fully evaluated and represents an area for future research.
The molecular basis of SINV encephalitis in mice
Entry into the tissues of the central nervous system (CNS) is partially determined by the route of inoculation, with the subcutaneous injection model being described as most similar to the natural route of infection via mosquito bite. After the development of viremia subsequent to replication at the site of infection, SINV crosses the blood-brain-barrier (BBB) [106,107]. Precisely how this occurs has not been definitively established, but SINV is capable of infecting and replicating in endothelial cells, and the instigation of an inflammatory response is known to induce BBB permeability or result in the potential migration of infected cells into the CNS [101,108]. Entry into the central nervous system can also occur via intranasal exposure, which is presumed to bypass the BBB through the infection of neuroepithelium and neurons innervating the nasal sensory neurons and vomeronasal organ/olfactory bulb [104,109,110]. As depicted in Figure 2B, entry to the brain is relatively rapid, with viral RNA detectable as early as 1dpi, with pronounced inflammatory responses including monocyte infiltration by 3dpi [111]. Once in the brain SINV infection spreads throughout the toward the midbrain/pons and brainstem. SINV pathophysiology is readily observable via hematoxylin and eosin (H&E) staining, with common signs of alphaviral-induced encephalitis being perivascular cuffing, monocytic infiltration, gliosis, and neuronal apoptosis [103,111–115]. As infection progresses, these phenomena lead to the death of motor neurons, and eventually, ascending paralysis. Lethality is derived from the death of neurons in the brainstem [116].
After entering the CNS, SINV readily infects multiple cell types in the brain including neurons, astrocytes, and microglia. While SINV infection can lead directly to the apoptosis of infected cells, SINV neuropathogenesis is undoubtedly the result of immunopathogenesis. This is supported by the observation that SCID mice completely lacking T- and B-cells are resistant to SINV neuropathogenesis despite the virus replicating to high titer in the infected animals [117,118]. Infections of mouse models lacking CD4+ T cells, but not CD8+ T cells, experience reduced neuroinflammation and mortality during lethal challenge [119,120]. It was later established that T-cells, in particular CD4+ TH17 T cells, are an important contributor to the development of pathogenesis during SINV infection. After infiltration into the brain the TH17 cells contribute to pathogenesis by expressing granzyme B, IL-22, and GM-CSF leading to heightened inflammation and apoptosis [121,122]. Studies evaluating the role of T-cells in the brain during SINV-induced encephalitis have revealed that IL-10 driven responses are protective of the central nervous tissue spaces during infection, as IL-10 suppresses pro-inflammatory stimulation leading to reduced cell death during infection [121–124]. In model systems lacking IL-10 viral clearance is increased, yet the associated inflammation is exacerbated leading to greater cell death [122–124].
Numerous studies have reported the upregulation of proinflammatory cytokines and chemokines in the mouse brain following infection, with notable examples of cytokines including IFNα/β, IFNγ, TNFα, GM-CSF (CSF2), LIF, and Interleukins-1; −4; −6; −12b; −17; and −23 [109,112,118,122,124–127]. Chemokines upregulated during SINV neuropathogenesis include CCLs 2 and 5, and CXCLs 9 and 10. As the type-I IFN response is critical to limiting viral infection through the induction of Interferon Stimulated Gene (ISG) expression resulting in an antiviral state, it has been shown that nonvirulent SINV gains lethality in the absence of a functional type-I IFN response [128]. In contrast, even though IFNγ contributes to the resolution of SINV infection, IFNγ-deficient models exhibit reduced disease severity due to the alteration of the infiltrating monocyte populations in the brain [126]. Mouse models with TNFα deficiencies exhibit reduced mortality and delayed onset of paralysis indicating that TNFα is a central contributor to SINV neuropathogenesis [129,130]. Interestingly, mice deficient in IL-1β are less susceptible to SINV in lethal challenge models despite exhibiting similar patterns of apoptosis and monocytic infiltration [114].
Neuronal death during SINV infection may also occur through a means outside of what is typically considered immunopathogenesis. One such mechanism is via neuronal excitotoxicity, where neurotransmitter levels, particularly those of glutamate, accumulate in the brain leading to the overstimulation of the postsynaptic cells. Overstimulation leads to death of the neuron due to ionic disbalance and metabolic dysregulation resulting in cell death and inflammation. Glutamate toxicity is induced during SINV infection via the downregulation of GLT-1 (also known as EAAT2) which is essential for removing glutamate from the synaptic cleft. Although neurotransmitter excitotoxicity is mechanistically distinct from conventional immunopathology, the downregulation of GLT-1 is driven by TNFα and IL-1β overexpression resulting in a blurry boundary between the two mechanisms [131,132].
SINV diagnostics and detection
In areas with endemic SINV, clinical detection is primarily based upon disease symptoms, medical history evaluations, and a general physical examination focusing on joint inflammation and pain [133]. As an arbovirus, clinical presentations of SINV disease usually follow a seasonal cycle due to the nature of the mosquito vector. People with suspected SINV infections are then evaluated using serological approaches to confirm the presence of anti-SINV IgM or IgG, typically through ELISA or other immunofluorescent clinical assays [5,134], and less often through plaque reduction neutralization assays [66]. In both methodologies, the magnitude of titer (or an increasing change in titer with time) of 4-fold is used to properly diagnose SINV infection [5]. As with all positive-sense RNA viruses, the presence of SINV is readily confirmed using RT-PCR or other nucleic acid-based detection modalities; yet, as SINV viremia concurs with the onset of symptoms and is short-lived nucleic acid-based tests are not relied upon clinically [135]. Virus isolation and culturing may also be used to confirm the presence of SINV, but the associated financial costs and specialized nature of doing so in relation to the likely clinical outcomes of SINV infection in humans precludes doing so in most cases.
SINV treatment and prevention
Clinically, SINV Fever is treated by general supportive care and symptomatic treatment as, to date, no clinically approved specific antiviral treatments for SINV infection exists. Typical treatment regimens include antihistamines to alleviate the itchiness associated with the maculopapular rash, and nonsteroidal anti-inflammatory drugs (NSAIDs) or analgesics like acetaminophen or ibuprofen to manage joint pain [68,133]. In cases where joint pain persists, or is exceptionally severe, the intra-articular administration of corticosteroids may be employed to reduce the underlying inflammation, but there is scant support for the efficacy of this treatment and steroid treatment may exacerbate viral infections [136]. The overall similarity of SINV musculoskeletal disease and Rheumatoid arthritis (RA) has led to interest in using anti-RA treatments for alphaviral-induced arthritis; however, studies involving other alphaviruses have indicated that the use of anti-RA drugs, such as Methotrexate, may complicate alphaviral infection leading to more severe disease [137].
Like the lack of SINV-specific antivirals, unfortunately, there are no licensed or clinically approved vaccines for the prevention of SINV infection in humans or animals. While several groups have pursued research applicable to vaccines for SINV, these efforts have failed to progress as SINV acute illness is typically considered mild and rarely causes serious permanent complications.
As is common to many mosquito-borne diseases, preventative efforts on a community scale could focus on reducing mosquito populations through either vector control or denying peridomestic mosquito species access to breeding environments in close proximity to human habitats. Other physical preventative measures include wearing appropriate protective clothing, avoiding outdoors activities during the time(s) of day when mosquitoes are likely to feed (dusk and dawn), and deploying insecticide/insect repellants to reduce feeding events.
The molecular life cycle of Sindbis virus
As mentioned above, SINV has been used extensively as a model pathogen by which the cellular and molecular replication biology of the alphaviruses have been studied. Accordingly, much of what is known about the molecular life cycle, as diagrammed in Figure 3 was first determined for SINV and then later applied to other alphaviruses. Only more recently have other alphaviruses been extensively investigated regarding replication, with one of the most notable recent accomplishments coming from the structural characterizations of the Chikungunya virus replication complex [138]. In addition, the majority of what is understood of alphaviral molecular replication has been gleaned from studies of vertebrate model systems. Where applicable, notable differences in alphaviral replication in vertebrates and invertebrates are noted below.
Figure 3.

The molecular life cycle of Sindbis virus in the host cell.
A diagram detailing key events during SINV infections of susceptible and permissive host cells of vertebrate (Top; with a blue background) and invertebrate (Bottom; with a pink background) derivations. Descriptions of key events may be found in the text of the document.
At the cellular level SINV infection begins with the adsorption and attachment of SINV virions, or viral particles, to the host cell via an interaction between the viral glycoproteins and host cell attachment factors and receptors. Heparan sulfate is known to act as a ubiquitous attachment factor/co-receptor for SINV [139,140]. As SINV exhibits broad host and tissue tropism it is highly likely that SINV utilizes a multitude of host receptors, with known host receptor proteins for SINV including DC-SIGN and L-SIGN [141], NRAMP2 [142], Laminin [143], MXRA8 [144], VLDLR and ApoER2 [145]. Importantly, the underlying biology of these receptors contribute to viral entry into the host cell cytoplasm by initiating receptor-mediated endocytosis of the viral particle [146]. Maturation of the endosome results in acidification leading to the conformational rearrangement of the viral glycoproteins to expose the fusion loop of the viral E1 glycoproteins [147–150]. The burial of the fusion loops into the membrane of the endosomal vesicle initiates the membrane fusion process which culminates in the release of the nucleocapsid core into the host cell cytoplasm (as reviewed in [146]).
The SINV nucleocapsid core is made up of 240 copies of the SINV Capsid (CP) protein and one viral genomic RNA [151,152]. Previous studies have indicated that host-derived factors may also be incorporated into alphaviral nucleocapsid cores, but the specific molecular functions of these host-derived factors during the lifecycle are unclear [153,154]. The nucleocapsid core is thought to undergo a rapid disassembly process initiated by elements of the host ribosomal machinery resulting in the dispersal of the CP protein and the release of the viral genomic RNA to the host cytoplasm [148,155,156]. Shortly thereafter, the viral genomic RNA becomes functionalized and acts as a mRNA for the synthesis of the viral replication machinery via the host translational machinery and the initiation of viral RNA synthesis/replication.
The SINV genomic RNA is approximately 12kb in length and has a 5’ type-0 7meGpppA cap structure and a 3’ polyadenylated tail [157]. In a manner identical to cellular mRNAs, the SINV genomic RNAs consist of protein-coding sequences flanked by 5’ and 3’ Untranslated Regions (UTRs) which serve to functionalize the viral RNA during infection. The sequence of the genomic RNA contains two coding-regions; however, only the 5’ open reading frame (ORF) corresponding to the viral replication machinery is translated from the genomic RNA. Thus, in the context of the genomic RNA the 3’ coding region exists as an extended 3’UTR unique to the viral genomic RNA.
Translation of the genomic RNA results in the synthesis of a pair of high-molecular weight polyproteins named P123 and P1234, depending on whether readthrough of the Opal stop codon between the nsP3 and nsP4 coding regions occurs [158,159]. In SINV, the Opal stop codon is part of a type II programmed ribosomal readthrough motif which leads to the synthesis of P1234 at a relative rate of ~ 5 to 20% in a temperature and host-dependent fashion [160]. These polyproteins are subsequently processed in a stepwise manner via the activity of the nsP2 protease domain in cis- and trans- to form functional replication complexes [161]. Initially, the transcriptionally inactive P1234 polyprotein is processed to liberate nsP4 to form the P123+nsP4 replication complex which predominantly synthesizes full length negative-sense viral RNAs colloquially referred to as the minus strand RNA [160]; however, the P123+nsP4 replication complex can also produce full-length positive-sense genomic RNAs [162]. As the translation of the viral genomic RNA continues resulting in the accumulation of viral nonstructural proteins, the half-life of the P123+nsP4 complex diminishes as the P123 polyprotein is rapidly processed to form nsP1 and a P23 cleavage intermediate [160,163–166]. Importantly, the cleavage of the nsP1 protein from the polyprotein marks the cessation of the synthesis of the minus strand template RNAs [160,167]. While the nsP1+P23+nsP4 replication complex is fully capable of synthesizing both the positive-sense genomic and subgenomic viral RNAs, the P23 intermediate is exceptionally short-lived due to increasing nonstructural protein accumulation [168]. As such, the synthesis of positive-sense genomic and subgenomic viral RNAs (which are produced at an excess rate of approximately 5 subgenomic RNAs per genomic RNA), is primarily the function of the fully mature replication complex consisting of nsP1, nsP2, nsP3, and nsP4 [160,167]. In contrast to the genomic RNA, the subgenomic RNA consists of solely the structural ORF accompanied by a unique 5’ UTR and a 3’UTR sequence of approximately 250 bases that is common to the genomic RNA.
The specific roles and molecular functions of the alphaviral nsPs during infection have been the subject of numerous thorough reviews [169–171]. Accordingly, the specificities of the nsPs outside of their roles as virulence factors will not be a subject of review here.
In vertebrates, the progression of the processing of the viral replicase complex is synchronized during infection due to the proteolytic processing of the polyprotein and the shutoff of host transcription via the activity of nsP2 protein, and translation via an unknown component of the subgenomic RNA/in response to PKR activation [172–176]. Collectively, the net result is that the synthesis of the nonstructural polyprotein wanes as the viral replicase complex becomes fully mature. The shutoff of host macromolecular synthesis is cytotoxic, and highly permissive host cells undergo cell death because of infection. In contrast, host transcription and translation are not significantly perturbed in invertebrate host cells resulting in the ongoing synthesis of nonstructural polyprotein throughout SINV infection [177].
As is true for most positive-sense RNA viruses, SINV replication is associated with host membranes [149,178,179]. These membranous compartments are referred to as spherules [149], and via recent investigations of the CHIKV replication complex using cryo-Electron Tomography (cryo-ET) have revealed a dodecameric ring of nsP1 proteins at the neck of the spherule which serves to stabilize the pore in addition to positioning the remaining nsP2 and nsP4 components in the neck of the ring-like structure [138]. The positioning of nsP3 is less clear but is believed to be outside the spherule in close association with the nsP2 protein. The negative-sense template minus strand RNA in duplex with the nascently synthesized positive-sense viral RNA is housed within the cocoa-pod like structure of the spherule, with the positive-sense viral RNA ultimately being extruded through the pore into the cytoplasm [180]. In vertebrate systems the replication spherules form on the plasma membrane where extensive arrays of the replication spherules form during viral replication, and large vacuolar structures deemed Cytopathic Vacuole type-I (CPV-I) are formed via endocytic pathways [181–184]. Formation of CPV-I structures is not required for viral RNA replication; however, the formation of CPV-I structures requires spherule formation, which is in turn dependent on the presence of a full complement of viral replication machinery and viral RNA synthesis [178,180,185–187]. The extent to which CPV-I structures are formed during infection varies across the alphaviral species, with evidence for SINV being on the lower end relative to other alphaviruses such as Semliki Forest virus (SFV) [178]. For SFV these cytoplasmic membranous structures have been determined to be derived from endosomal/lysosomal membranes and are dependent on host processes, including the activation of the PI3K-Akt-mTOR pathway [188–190]. Several hypotheses for the mechanistic importance of the CPV-I structures have been proposed, including the evasion of the induction of cellular responses via the obscuring of the viral replication intermediates [190], and a hand-in-hand role in assembly during nucleocapsid formation [184].
During infections of mosquito cells, vacuolar structures akin to those formed during vertebrate infection are formed and readily identified via transmission electron micrography. Regardless, these structures have notable differences when compared to the CPV-I structures, the primary of which being the presence of intact internally budded viral particles within the vesicle lumen. Additionally, the replication spherules are derived from internal endocytic membranes rather than the plasma membrane [184].
Translation of the subgenomic RNA leads to the production of the viral structural polyprotein, which, after proteolytic processing via viral and host proteases, yields the viral CP protein, E3; E2; and E1 glycoproteins, and either the 6k or TF protein [191]. The ordering of the SINV structural proteins encoded by the structural ORF is CP-E3-E2-6k/TF-E1 and depending on whether a programmed frameshift occurs, the polyproteins resulting from translation of the subgenomic viral RNA are either CP-E3-E2-6K-E1 or CP-E3-E2-TF as the frameshift that results in the production of TF abrogates the synthesis of the E1 glycoprotein. In all cases, the CP protein autoproteolytically cleaves itself from E3 during translation [151,192]. The recognition of a signal sequence by the host translational machinery in the N-terminus of E3 directs the remaining structural polyprotein synthesis to occur via the host endoplasmic reticulum (ER) where host peptidases are responsible for cleaving the structural polyprotein into the individual structural proteins [193–195]. As with the nonstructural polyprotein, the cleavage of the structural polyproteins occurs in a stepwise fashion. Initially, the CP-E3-E2-6K-E1 polyprotein is cleaved at the E2-6k/TF and 6k-E1 junctions by host Signalase to form the precursor protein PE2, which consists of the E3-E2 glycoproteins, and the E1 glycoprotein, respectively [196]. In the context of the PE2 protein, the E3 protein serves to orchestrate the structural maturation of the E2 protein until its later cleavage into the mature E3 and E2 monomers via the host furin protease [197]. The PE2 and E1 glycoproteins form a complex that continues to be proteolytically processed and structurally matured and glycosylated in the Golgi apparatus, eventually resulting in their trafficking to the plasma membrane as trimers of E1 and E2 heterodimers [198]. While some alphaviruses retain the E3 protein as part of their viral particle, SINV does not include E3 as part of the mature final virion [199]. The synthesis of the CP-E3-E2-TF polyprotein occurs at a rate of ~10–15% [200,201], and is similarly processed to that described above. Nevertheless, as the programmed frameshift abrogates the production of E1 it is unclear as to how the PE2 formed from this polyprotein ultimately contributes to the formation of the mature glycoprotein spike complex. Although similar at the N-terminus, and both being palmitoylated via host machinery, the 6k and TF proteins have diverging functions during the viral lifecycle. The 6k protein has been ascribed viroporin activity and has been shown to facilitate CPV-II formation and viral assembly despite not being incorporated into viral particles [202–204]. The TF protein is incorporated into mature viral particles and is also involved in viral particle assembly as mutants lacking TF form irregular viral particles with structural abnormalities [205–208].
The final stages of the SINV lifecycle involve the assembly of nascent viral particles from the accumulating viral RNAs and structural proteins. Much of the alphaviral assembly process remains unclear, but the formation of specific subassembly intermediates leading to formation of mature viral particles is clear [209]. One such subassembly intermediate is the formation of new cytoplasmic nucleocapsid cores once the viral CP protein recognizes the packaging signal (PS) present in the viral genomic RNA [210–212]. The precise location of the PS differs amongst the alphaviruses, where in SINV the PS is present in the nsP1 gene [213]. Regardless, the recognition of PS by the CP protein is essential to the specific selection of viral particle cargo and is believed to initiate the nucleation of the CP protein to the viral RNA resulting in core assembly, yet the specificities of nucleocapsid core assembly remain ambiguous [209]. The nascent nucleocapsid core then engages with the viral glycoproteins resulting in envelopment and formation of the mature viral particle [214,215]. As with the viral replication compartments formed during alphaviral infection, CPV-II’s, internal membranous structures that are rich with preassembly intermediates and fully assembled intracellular particles, are formed in vertebrate cells during assembly [216,217]. The release of viral particles from the host cell occurs at the plasma membrane following interactions of the viral glycoproteins with the cytoplasmic nucleocapsid cores or through extensive extracellular projections from the host cell [218]. Alternatively, during mosquito infections intracellular mature viral particles may be formed via budding into the membranous replication vesicle [184].
The identification of Sindbis virus virulence traits
The knowledgebase of SINV pathogenesis with specific regards to virulence determinants is the product of many years of study using a highly advantageous approach that has been proven time and time again for many viruses. Non-neurotropic and neurotropic SINV infections are known to occur with several “wild type” strains of SINV isolated from mosquito and human populations and laboratory adapted strains. Importantly, comparative studies between these virulent and avirulent strains have led to the identification of key virulence determinants and a greater understanding of alphaviral neuropathogenesis/disease.
The prototypic strain of SINV, strain AR339 was first isolated in Egypt in 1952 by subculturing extracts from a mixed pool of Culex spp. mosquitoes [33]. The AR339 strain was further passaged in the laboratory resulting in the accumulation of polymorphisms that altered its phenotype, leading to the development of the infectious clone TR339, which faithfully recapitulated the mild neurovirulent properties of the original parental isolate [219–221]. Through a series of tissue culture and animal adaptation studies virulent and avirulent SINV laboratory strains were developed. Adaptation of the AR339 strain in the 1970’s led to the development of the SV1A strain which is poorly neuroinvasive but moderately neurovirulent, as well as the NSV strain which is highly neuroinvasive and neurovirulent [116,222]. In the late 1980’s a series of recombinant clones of the lab adapted HRsp (Heat Resistant small plaque) SINV isolate were developed, resulting in the pToto-derived SINV strain family, which ultimately led to a revolution in the understanding of alphaviral molecular replication [223]. As these pToto-derived strains lack the capacity to replicate in vivo, they do not cause SINV disease in mouse models of infection unless the mouse model is severely immunocompromised or practically neonatal [224]. Nonetheless, through recombination of the pToto, SV, and NSV strains a virulent recombinant strain TE was generated with which the role of the viral glycoproteins during pathogenesis was determined [225]. The isolation of a non-virulent SINV strain from a mosquito pool in Israel (SINV.Peleg) followed by serial passage in suckling and weanling mice led to the development of a series of adapted laboratory strains, SV (which is neither invasive or virulent), SVN (which was neurovirulent if intracranially injected), and SVNI (which was both neurovirulent and capable of neuroinvasion) [106,226]. Contemporarily with these efforts, a pair of natural SINV isolates were isolated and reported, strain AR86 and Girdwood, which were isolated from mosquito pools and a human patient, respectively [227,228]. The AR86 strain was found to be naturally neuroinvasive and neurovirulent, whereas the Girdwood strain was neuroinvasive but generally avirulent [229]. In addition, comparative analysis of virulent and avirulent strains have also led to the development of site-specific mutant strains with polymorphisms of interest in clean backgrounds such as TR339 and the Toto-derived strain family.
As mentioned above, the comparative assessments of the above viral strains have been used to define the neuroinvasion and neurovirulence determinants of SINV. The major findings of these efforts are described below in the context of either the viral life cycle or the host response to viral infection and are summarized in Table 1. Instances where a specific role or function of a viral component is integral to virus replication and hence by knock-on effect pathogenesis- for instance, the capacity of the nsP2 protease to cleave the P123 polyprotein enabling replication, are not considered separable virulence determinants and will not be discussed.
Virulence factors affecting viral attachment and entry
The capacity for SINV to interact with host receptors is critical to the overall pathogenesis/virulence in vivo. Expectedly, many of the early neuroinvasion and neurovirulence determinants have been found to be within the viral E2 and E1 glycoproteins [230]. The SINV E2 glycoprotein is responsible for receptor engagement via the glycosylated ectodomain during the entry pathway whereas the endodomain of E2 extends inwards past the viral envelope where it engages with a hydrophobic pocket in the viral capsid protein [215,231–233]. The E2 protein is organized into four domains, with Domain A as the primary receptor-binding region. Domain B of the E2 protein is the apex of the glycoprotein spike complex, and Domain C mediates extensive contacts with the E1 glycoprotein and is critical for spike stability and the regulation of fusion. Domain D is internal to the viral envelope and is involved with capsid protein binding during assembly and maturation. The E1 protein is a class II fusion protein which disengages from E2 and trimerizes in response to endosome acidification during the viral entry pathway [146,234,235]. The E1 protein itself is organized into three domains. Domain I of the E1 glycoprotein is a highly conserved central domain that acts as a scaffold and is involved in the confirmational rearrangements of the spike complex during entry. Domain II, which contains the fusion loop, extends outward from Domain I and interacts with E2 to maintain the spike complex [236]. Finally, Domain III is an immunoglobulin-like fold that is attached to the stem region and C-terminal transmembrane domain and is involved in the fold-back mechanism leading to membrane fusion.
Based on the functional importance of Domains A and B of the E2 protein, it is unsurprising that a number of virulence determinants have been identified in this region. Specifically, comparative analysis of virulent and avirulent viruses led to the identification of residues R1, H55, K70, and S114 of Domain A, S114 in the Domain A-B linker, and R157 and K159 of Domain B as virulence determinants involved in the engagement of heparan sulfate (HS) moieties during the viral entry process [106,110,140,219,224,225,237–247]. In the case of the H55 residue the lysine residue at position 70 (K70) was required for full virulence [140,237]. As noted above, the residues at R157 and K159 are involved in the engagement of HS but also individually exhibited differences in replication within the cells of the central nervous system through a mechanism that is unclear [246,247]. Altogether, these mutations were ultimately found to mediate enhanced binding to Heparan Sulfate (HS), a ubiquitously expressed extracellular moiety, leading to enhanced viral attachment and entry. Along a similar vein, the mutation of E2 residues that are typically glycosylated, namely N196Q and N318Q, resulted in increased virulence presumably due to altered HS interactions [248]. In addition to the virulence determinants found in Domains A and B, several residues critical for entry/virulence have been identified in Domain C and the C-stem region of E2. These include R172, M190, S243, and K260 (which coordinates with M190), which have been shown or are postulated to be involved in receptor binding [106,229,239,249].
As part of the glycoprotein spike complex, and the source of the fusion loop, residues in the E1 protein have also been identified as major virulence determinants. These include residues A72, D75, V80; and G172, P226, and A237 of Domain II [224,225,244,250–252]; and D313 in Domain III [225]. The precise impacts of the V72A and G313D residues on E1 function are unclear, yet inferences may be made based on the location of the residues in the larger structure of the E2/E1 glycoprotein spike complex [225]. The V72A residue is close to the apical end of the E1 glycoprotein and may influence the activity of the fusion loop. The G313D residue is located in Domain III and may influence inter E1/E2 interactions during entry. Residue V80L in the E1 glycoprotein has also been demonstrated to be important for SINV infection in vitro in both mammalian and mosquito cell lines [250]. Likewise, residue P226S has also been shown to greatly influence SINV infection by influencing the requirement for cholesterol [252]. Other residues of E1 have been also established as important to alphaviral pathogenesis, including D75, and A237, but the precise mechanism(s) by which they act is unclear [224,225,244].
Virulence factors affecting the host innate immune response
A robust innate immune response is critical to inhibiting viral infection and spread within the host and is key to limiting pathogenesis by reducing the overall infectious burden within the host [128]. As mentioned earlier, the effects of type-I IFN expression on alphaviral infection and pathogenesis are pronounced, as alphaviruses are susceptible to many of the IFN-stimulated effector ISGs [128]. Thus, it is unsurprising that the alphaviruses have developed a multifaceted interface with the host that includes numerous and often redundant mechanisms by which the induction of an innate immune response is evaded or blunted during an infection.
Innate immune evasion traits of the SINV viral RNAs
Several studies noted that the primary sequence of the noncoding regions of SINV were integral to virulence. Specifically, comparative analysis of the lab adapted SVN and SVNI strains revealed that nt5 and nt8 of the SINV 5’UTR were important to neurovirulence [220,249,253]. At the time the precise reason was unclear; however, later investigations into a similar phenomenon in VEEV revealed that structures in the alphaviral genomic 5’ UTR are critical to the evasion of innate immune detection of the type-0 cap structure [254].
In addition to the virulence traits present in the SINV genomic 5’UTR, the subgenomic 5’UTR also possesses at least one element critical to pathogenesis. Downstream of the CP protein start codon, an RNA secondary structure termed the Downstream Loop element (DLP) serves to guide the initiation of translation to the proper start codon during viral infection [174,255–257]. The activity of the DLP is critical to viral structural gene expression, and by extension pathogenesis, as the host PKR pathway recognizes viral double-stranded RNA resulting in the phosphorylation of eIF2α and subsequent translational shutoff [172]. SINV replication is significantly attenuated in vivo in the absence of the DLP, which (although not directly shown) certainly impacts virulence [173].
Related observations have been made regarding the alphaviral 3’UTR, yet uncertainty remains regarding the presence of identified virulence traits in SINV. This is partially due to a lack of complementary investigations confirming observations that have been made in cell culture in genuine in vivo models of infection. Examples of this include regions of the 3’UTR known to direct either replication efficiency, translational fitness (occasionally in a host-specific manner), or RNA stability with the latter two examples being dependent on the engagement of host RNA-binding proteins [258,259]. Regardless, some known alphavirus 3’UTR virulence traits, such as the presence of miRNA binding sites in the 3’UTR of EEEV, are known to not be conserved in SINV [260]. Hence, the full impact of the 3’UTR on SINV virulence, and indeed alphaviral pathogenesis, requires further investigation.
More recently, it was demonstrated that a significant number of positive-sense RNAs lacking a 5’ cap structure are synthesized during SINV infection [261,262]. Further investigations revealed this to be common to other alphaviruses, and the production of the noncapped genomic RNA species was also observed in vivo [154,261]. While it is currently unclear as to precisely how these noncapped RNAs are produced during infection, the nsP1 protein, which is the viral capping enzyme [263–266], was implicated through comparative analysis of virulent and avirulent RRV strains. Taking cue from studies examining VEEV nsP1 capping activity in vitro [267], point mutations of the SINV nsP1 protein were demonstrated to alter their production during viral infection [262]. One such mutant, nsP1 D355A, which decreases the production of noncapped viral genomic RNAs, is significantly attenuated in vivo [103]. In contrast, increasing the production of the noncapped genomic RNAs via the nsP1 N376A mutation did not significantly alter neurovirulence. Paradoxically, increasing the proportion of capped genomic RNAs, despite diminishing the impact of the type-I IFN response on SINV infection, reduced the production and infectivity of SINV particles [103,262,268]. Later investigations specifically examining the impact of the noncapped genomic RNAs on viral infectivity revealed viral translational enhancement early during infection as an underlying virulence trait [268].
Innate immune evasion traits of the SINV nonstructural proteins
Comparative studies involving the neurovirulent AR86 strain and the avirulent Girdwood strain revealed the threonine residue at position 538 as critically important to neurovirulence in the AR86 strain [269,270]. This particular residue lies within the nsP2 cleavage site between nsP1 and nsP2, and incorporating a I538T mutation in the Girdwood strain is sufficient to impart enhanced virulence, albeit modestly. The precise mechanism underlying this virulence determinant is unclear but undoubtedly involves the regulation of the type-I IFN response. Curiously, the mechanism of action of the 538T residue is independent of the host shutoff of transcription afforded by nsP2 (described in more detail below), suggesting an alternative impact on nsP1 or P123 biology [270]. Two other virulence determinants in the nsP1 protein have been described, namely T173 and R425, which are in the MTAse and Membrane Association domains, respectively [106,271]. The precise functions of these residues are unclear, but they presumably alter capping efficiency or replicase complex formation.
In addition to cleaving the nonstructural polyprotein, the SINV nsP2 protein is critical to the shutoff of host transcription through the proteolytic degradation of RPB1, the major catalytic subunit of the host RNA polymerase II complex [272,273]. Importantly, the degradation of RPB1 following SINV gene expression is the primary means by which the host response to infection is curtailed. Point mutations unable to direct the degradation of RPB1, such as the P726G mutation, are significantly attenuated and result in persistent infection at the cellular level in tissue culture models of infection [273,274]. The role of the alphaviral nsP2 protein in host transcriptional inhibition is unique to the Old-World alphaviruses, as the New World alphaviruses rely on the activity of the CP protein to accomplish a similar end [175].
The nsP3 protein, in addition to serving as a scaffold for the interaction of numerous host factors in a species-dependent manner (both host and virus), possesses a Macrodomain with ADP-ribosyl binding and hydrolase activities. Mutation of residues N10 and N24 are inferred to reduce ADP-ribosylase activity resulting in attenuation [275], and mutations in both the binding and hydrolase functional domains of the nsP3 protein, namely at residues 32 and 114, result in attenuation and loss of neurovirulence [276]. Mechanistically, precisely how the loss of ADP-ribosylase activity contributes to a reduction in IFN expression is unknown and in need of continued examination. The nsP3 Hyper Variable Domain (HVD) is also involved in virulence, as the deletion of residues 386 to 403 results in attenuation in vivo, likely through the disruption of host/pathogen interactions [229]. Potential mechanisms include the restructuring of the host stress granule microenvironment to enhance viral gene expression and replication.
While not a coding change perse, the Opal stop codon between nsP3 and nsP4 is also an important virulence trait as demonstrated by comparative studies of the virulent AR86 and avirulent Girdwood strains of SINV [229]. Specifically, SINV AR86 lacks the Opal stop codon and encodes a cysteine residue in its place resulting in the constitutive production of the nonstructural P1234 polyprotein [229]. While replacing the Opal stop codon in the AR86 strain did not eliminate virulence, mortality on the whole was reduced 2-fold and survival was prolonged by approximately 2 days (229). Precisely how the increased synthesis of P1234 enhances virulence has not been rigorously examined, yet the most likely mechanism is self-explanatory as increased synthesis of the viral replication complex leads to knock-on effects throughout the viral lifecycle (as P123 cannot replicate viral RNA in the absence of nsP4).
Innate immune evasion traits of the SINV structural proteins
The SINV CP protein plays a critical role in the evasion of the induction of an innate immune response by masking the detection of viral Pathogen Associated Molecular Patterns (PAMPs) during infection [277,278]. Specifically, the SINV CP protein was found to interact with the host IRAK1 kinase resulting in a significantly reduced capacity to sense and respond to TLR ligands [277]. The inhibition of PAMP via TLR-based detection was found to not require viral gene expression, revealing that the viral CP protein derived from the incoming viral particles was capable of masking viral infection regardless of infectious potential [277]. Mutational analyses revealed that the inhibition of IRAK1 signaling was due to residues within the RII domain of the SINV CP protein [278]. Importantly, further studies determined that this particular function of the RII domain was highly conserved amongst the other alphaviruses. Loss of the critical interaction residues in SINV resulted in complete loss of neuroinvasiveness due to a robust innate immune response, and intracranial infections revealed altered neuropathogenesis suggesting an additional role for the interaction beyond the masking of TLR-sensing [278].
Interactions between the SINV CP protein and the viral genomic RNA have also been found to contribute to viral pathogenesis; however, the underlying mechanism remains unclear and is partially confounded by the nature of the interaction site mutants themselves [279]. The impact of the CP viral genomic RNA interaction was assessed via the disruption of the CP interaction sites by way of the incorporation of silent mutations throughout the interaction site. Of the three high specificity interaction sites, the mutation of two sites were found to be attenuating, specifically those at nt9300 and nt10100. Unfortunately, the robust attenuation observed with the nt10100 site is undoubtedly influenced by the alteration of the TF protein (which coincides with the CP RNA binding site) [206,279]. Examinations of the more mildly attenuating mutant of the nt9300 interaction site indicated a potential role in viral RNA stability and the evasion of the type-I IFN response.
As noted in the paragraph above, the TF protein, which is produced at a reduced rate to all other SINV structural proteins, is known to be important to the evasion of the host innate immune response. Indeed, mutants that produce solely the 6k protein during infection, or mutants of the TF protein which are incapable of being palmitoylated, are highly attenuated in vivo (206). Precisely how the TF contributes to the evasion of the innate immune response, directly or indirectly, is uncertain.
Conclusions and future directions
Although SINV has been extensively used as a model alphavirus for the purposes of defining alphaviral replication biology and alphaviral-induced encephalitis, much remains unknown regarding the pathogenesis of the complex rash/arthritis syndrome known as SINV Fever in humans. SINV has been neglected as a clinically relevant arbovirus that exhibits a broad geographic range rich with immunologically naïve individuals. As time has recently demonstrated through the global outbreaks of arboviral disease, pathogens such as SINV are readily impacted by climatological changes and under the right conditions explosive outbreaks of disease may occur. As it becomes more and more apparent that prior infections and inflammatory insults may contribute to the later development of morbidities and the response to future infections, understanding pathogens that have been long presumed to be inconsequential to human health becomes increasingly important. Thus, continued SINV research is not only critical to the understanding of alphaviral infections and pathogenesis, but also to public health efforts by which future outbreaks may be mitigated.
As described earlier, a major challenge preventing a full understanding of SINV virulence is the lack of a model system that faithfully recapitulates SINV fever disease as it presents clinically in humans. To some extent the mechanisms underlying human arthritogenic alphaviral diseases, such as those of CHIKV, RRV, and MAYV, appear to be broadly applicable to human SINV infections and pathogenesis. Therefore, comparative studies across the arthritogenic alphaviruses using mouse models of infection may continue to provide meaningful insights into human SINV infections. While nonhuman primates have been used to examine the pathogenesis of other alphaviruses, such as EEEV [280], given the lack of lethal SINV infections in humans, there is little pressing need or rationale for doing so with SINV. The use of human organoids modeling the synovial joints or primary tissue samples to investigate SINV infection represents a pathway by which aspects of SINV pathogenesis may be probed in models adjacent to genuine human infections. The pairing of molecular investigations involving these model systems with clinical samples represents a means by which SINV-specific pathogenesis in humans may be better understood and the development of novel antiviral therapeutics identified.
Supplementary Material
Funding Statement
This work was funded by grants from the National Institute of Allergy and Infectious Diseases (NIH-NIAID) and National Institute of General Medical Sciences (NIGMS), specifically [R01 AI153275] and [R01 AI185075] to K.J.S.; and by a COBRE program grant from the National Institute of General Medical Sciences (NIGMS), [P20 GM125504] to K.J.S. and R. Lamont. Additional support was received from the Integrated Programs in Biomedical Sciences (IPIBS) to C.M.I, D.K, S.M, and a generous startup package from the University of Louisville to K.J.S. This work was supported in part by a grant from the Jewish Heritage Fund for Excellence Research Enhancement Grant Program at the University of Louisville School of Medicine.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Data availability statement
The authors confirm that the data supporting the findings of this study are available within the article, and that there is no new primary data associated with this research.
Supplemental data
Supplemental data for this article can be accessed online at https://doi.org/10.1080/21505594.2025.2609389
References
- [1].Fauquet CM. Taxonomy, classification and nomenclature of viruses. In: Mahy B, Van Regenmortel M, editors. Encyclopedia of virology. Third ed. Oxford: Academic Press; 2008. p 9–26. doi: 10.1016/B978-012374410-4.00509-4 [DOI] [Google Scholar]
- [2].Lefkowitz EJ, Dempsey DM, Hendrickson RC, et al. Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV). Nucleic Acids Res. 2018;46(D1):D708–D717. doi: 10.1093/nar/gkx932 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Kurkela S, Manni T, Vaheri A, et al. Causative agent of Pogosta disease isolated from blood and skin lesions. Emerg Infect Dis. 2004;10(5):889–894. doi: 10.3201/eid1005.030689. PMC3323234 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Kurkela S, Manni T, Myllynen J, et al. Clinical and laboratory manifestations of Sindbis virus infection: prospective study, Finland, 2002–2003. J Infect Dis. 2005;191(11):1820–1829. doi: 10.1086/430007 [DOI] [PubMed] [Google Scholar]
- [5].Manni T, Kurkela S, Vaheri A, et al. Diagnostics of Pogosta disease: antigenic properties and evaluation of Sindbis virus IgM and IgG enzyme immunoassays. Vector Borne Zoonotic Dis. 2008;8(3):303–312. doi: 10.1089/vbz.2007.0623 [DOI] [PubMed] [Google Scholar]
- [6].Lvov DK, Vladimirtseva EA, Butenko AM, et al. Identity of Karelian fever and Ockelbo viruses determined by serum dilution-plaque reduction neutralization tests and oligonucleotide mapping. Am J Trop Med Hyg. 1988;39(6):607–610. doi: 10.4269/ajtmh.1988.39.607 [DOI] [PubMed] [Google Scholar]
- [7].Skogh M, Espmark A. Ockelbo disease - epidemic arthritis-exanthema syndrome in Sweden caused by Sindbis-virus like agent. Lancet. 1982;319(8275):795–796. doi: 10.1016/S0140-6736(82)91834-7 [DOI] [PubMed] [Google Scholar]
- [8].Niklasson B, Espmark A, Leduc JW, et al. Association of a Sindbis-like virus with Ockelbo disease in Sweden. Am J Trop Med Hyg. 1984;33(6):1212–1217. doi: 10.4269/ajtmh.1984.33.1212 [DOI] [PubMed] [Google Scholar]
- [9].Lvov DK, Skrovtsova TM, Kondrashina NG, et al. Etiology of Karelian fever, a new arbovirus infection. Vopr Virusol. 1982;27(6):690–692. [PubMed] [Google Scholar]
- [10].Malherbe H, Strickland-Cholmley M, Jackson AL. Sindbis virus infection in man. Report of a case with recovery of virus from skin lesions. S Afr Med J. 1963;281(7293):547–552. doi: 10.1016/S0140-6736(63)91911-1 [DOI] [PubMed] [Google Scholar]
- [11].Haddow A. Annual report. East African Council for Medical Research Annual report. 1961/62:8. [Google Scholar]
- [12].Ben-Porath E, Fattal B, Goldblum N, et al. Occurrence of antibodies to Sindbis virus in children from a West Nile endemic area. ISR J Med Sci. 1965;1:88–90. [PubMed] [Google Scholar]
- [13].Nir Y, Goldwasser R, Lasowski Y, et al. Isolation of arboviruses from wild birds in Israel. Am J Epidemiol. 1967;86(2):372–378. doi: 10.1093/oxfordjournals.aje.a120747 [DOI] [PubMed] [Google Scholar]
- [14].Balducci M, Verani P, Lopes MC, et al. Survey for antibodies against arthropod-borne viruses in man and animals in Italy. ii. Serologic status of human beings in a northern Italian region (Gorizia Province). Am J Trop Med Hyg. 1967;16(2):211–215. doi: 10.4269/ajtmh.1967.16.211 [DOI] [PubMed] [Google Scholar]
- [15].Saikku P. Occurrence of a group a hemagglutination inhibiting activity in Finnish serum material. In: Arboviruses of the California Complex and the Bunyamwera Group: proceedings of the Symposium held at Smolenice near Bratislava, October 18–21, 1966. Bratislava (Czechoslovakia): Slovak Academy of Sciences; 1966. p. 375–378. [Google Scholar]
- [16].Pavlatos M, Smith CE. Antibodies to arthropod-borne viruses in Greece. Trans R Soc Trop Med Hyg. 1964;58(5):422–424. doi: 10.1016/0035-9203(64)90089-6 [DOI] [PubMed] [Google Scholar]
- [17].Kurkela S, Ratti O, Huhtamo E, et al. Sindbis virus infection in resident birds, migratory birds, and humans, Finland. Emerg Infect Dis. 2008;14(1):41–47. doi: 10.3201/eid1401.070510. PMC2600146 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Sane J, Guedes S, Kurkela S, et al. Epidemiological analysis of mosquito-borne Pogosta disease in Finland, 2009. Euro Surveill. 2010;15(2). doi: 10.2807/ese.15.02.19462-en [DOI] [PubMed] [Google Scholar]
- [19].Espmark A, Niklasson B. Ockelbo disease in Sweden - epidemiological, clinical, and virological data from the 1982 outbreak. Am J Trop Med Hyg. 1984;33(6):1203–1211. doi: 10.4269/ajtmh.1984.33.1203 [DOI] [PubMed] [Google Scholar]
- [20].Skogh M, Westermark SE. Augustiexanthem med arthralgier (August exanthema with arthralgia). In: Annual meeting of the Swedish Dermatological Association; 1973. [Google Scholar]
- [21].Brummer-Korvenkontio M, Vapalahti O, Kuusisto P, et al. Epidemiology of Sindbis virus infections in Finland 1981–96: possible factors explaining a peculiar disease pattern. Epidemiol Infect. 2002;129(2):335–345. doi: 10.1017/S0950268802007409. PMC2869892 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Lundstrom JO, Vene S, Espmark A, et al. Geographical and temporal distribution of Ockelbo disease in Sweden. Epidemiol Infect. 1991;106(3):567–574. doi: 10.1017/S0950268800067637 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Storm N, Weyer J, Markotter W, et al. Human cases of Sindbis fever in South Africa, 2006–2010. Epidemiol Infect. 2014;142(2):234–238. doi: 10.1017/S0950268813000964. PMC9151170 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Doherty RL, Bodey AS, Carew JS. Sindbis virus infection in Australia. Med J Aust. 1969;2(20):1016–1017. doi: 10.5694/j.1326-5377.1969.tb107563.x [DOI] [PubMed] [Google Scholar]
- [25].Jupp PG, Blackburn NK, Thompson DL, et al. Sindbis and West Nile virus infections in the Witwatersrand-Pretoria region. S Afr Med J. 1986;70(4):218–220. [PubMed] [Google Scholar]
- [26].McIntosh BM, Jupp PG, Dos Santos I, et al. Epidemics of West Nile and Sindbis viruses in South Africa with Culex (Culex) univittatus Theobald as vector. South Afr J Sci. 1976;72:295–300. [Google Scholar]
- [27].McIntosh BM, McGillivray GM, Dickinson DB, et al. Illness caused by Sindbis and West Nile viruses in South Africa. S Afr Med J. 1964;38:291–294. [PubMed] [Google Scholar]
- [28].Findlay GH, Whiting DA. Arbovirus exanthem from Sindbis and West Nile viruses. Br J Dermatol. 1968;80(2):67–74. doi: 10.1111/j.1365-2133.1968.tb12262.x [DOI] [Google Scholar]
- [29].Bergqvist J, Forsman O, Larsson P, et al. Detection and isolation of Sindbis virus from mosquitoes captured during an outbreak in Sweden, 2013. Vector Borne Zoonotic Dis. 2015;15(2):133–140. doi: 10.1089/vbz.2014.1717 [DOI] [PubMed] [Google Scholar]
- [30].Fourie I, Snyman J, Williams J, et al. Epidemiological and genomic characterisation of Middelburg and Sindbis alphaviruses identified in horses with febrile and neurological infections, South Africa (2014–2018). Viruses. 2022;14(9). doi: 10.3390/v14092013. PMC9501102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Gylfe A, Ribers A, Forsman O, et al. Mosquitoborne Sindbis virus infection and long-term illness. Emerg Infect Dis. 2018;24(6):1141–1142. doi: 10.3201/eid2406.170892. PMC6004841 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [32].Gutiérrez-López R, Ruiz-López MJ, Ledesma J, et al. First isolation of the Sindbis virus in mosquitoes from southwestern Spain reveals a new recent introduction from Africa. One Health. 2025;20:100947. doi: 10.1016/j.onehlt.2024.100947. PMC11699435 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33].Taylor RM, Hurlbut HS, Work TH, et al. Sindbis virus: a newly recognized arthropodtransmitted virus. Am J Trop Med Hyg. 1955;4(5):844–862. doi: 10.4269/ajtmh.1955.4.844 [DOI] [PubMed] [Google Scholar]
- [34].Adouchief S, Smura T, Sane J, et al. Sindbis virus as a human pathogen-epidemiology, clinical picture and pathogenesis. Rev Med Virol. 2016;26(4):221–241. doi: 10.1002/rmv.1876 [DOI] [PubMed] [Google Scholar]
- [35].Lundstrom JO, Pfeffer M. Phylogeographic structure and evolutionary history of Sindbis virus. Vector Borne Zoonotic Dis. 2010;10(9):889–907. doi: 10.1089/vbz.2009.0069 [DOI] [PubMed] [Google Scholar]
- [36].Chen R, Mukhopadhyay S, Merits A, et al. Ictv virus taxonomy profile: togaviridae. J Gen Virol. 2018;99(6):761–762. doi: 10.1099/jgv.0.001072 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37].Michie A, Ernst T, Pyke AT, et al. Genomic analysis of Sindbis virus reveals uncharacterized diversity within the Australasian region, and support for revised SINV taxonomy. Viruses. 2023;16(1):7. doi: 10.3390/v16010007. PMC10820390 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [38].Saleh SM, Poidinger M, Mackenzie JS, et al. Antigenic and genetic typing of Whataroa viruses in Australia. Am J Trop Med Hyg. 2004;71(3):262–267. doi: 10.4269/ajtmh.2004.71.262 [DOI] [PubMed] [Google Scholar]
- [39].Olson K, Trent DW. Genetic and antigenic variations among geographical isolates of Sindbis virus. J Gen Virol. 1985;66(4):797–810. doi: 10.1099/0022-1317-66-4-797 [DOI] [PubMed] [Google Scholar]
- [40].Wu-Yang Z, Guo-Dong L. Research on basis of reverse genetics system of a Sindbis-like virus XJ-160. Virol J. 2011;8(1):519. doi: 10.1186/1743-422X-8-519. PMC3245537 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [41].Liang GD, Li L, Zhou GL, et al. Isolation and complete nucleotide sequence of a Chinese Sindbis-like virus. J Gen Virol. 2000;81(5):1347–1351. doi: 10.1099/0022-1317-81-5-1347 [DOI] [PubMed] [Google Scholar]
- [42].Al’khovskiĭ SV, L’Vov DK, Shchelkanov M, et al. Complete genome characterization of the Kyzylagach virus (KYZV) (Togaviridae, Alphavirus, Sindbis serogroup) isolated from mosquitoes Culex modestus Ficalbi, 1889 (Culicinae) collected in a colony of herons (Ardeidae Leach, 1820) in Azerbaijan. Vopr Virusol. 2014;59:27–31. [PubMed] [Google Scholar]
- [43].Hesson JC, Lundström JO, Tok A, et al. Temporal variation in Sindbis virus antibody prevalence in bird hosts in an endemic area in Sweden. PLOS ONE. 2016;11(8):e0162005. doi: 10.1371/journal.pone.0162005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [44].Lundström JO, Turell MJ, Niklasson B. Viremia in three orders of birds (Anseriformes, Galliformes and Passeriformes) inoculated with Ockelbo virus. J Wildl Dis. 1993;29(2):189–195. doi: 10.7589/0090-3558-29.2.189 [DOI] [PubMed] [Google Scholar]
- [45].Lundström JO, Lindström KM, Olsen B, et al. Prevalence of Sindbis virus neutralizing antibodies among Swedish passerines indicates that thrushes are the main amplifying hosts. J Med Entomol. 2001;38(2):289–297. doi: 10.1603/0022-2585-38.2.289 [DOI] [PubMed] [Google Scholar]
- [46].Sane J, Guedes S, Ollgren J, et al. Epidemic Sindbis virus infection in Finland: a population-based case-control study of risk factors. J Infect Dis. 2011;204(3):459–466. doi: 10.1093/infdis/jir267 [DOI] [PubMed] [Google Scholar]
- [47].Lundström JO. Mosquito-borne viruses in Western Europe: a review. J Vector Ecol. 1999;24(1):1–39. [PubMed] [Google Scholar]
- [48].McIntosh BM, McGillivray GM, Dickinson DB, et al. Ecological studies on Sindbis and West Nile viruses in South Africa. IV. Infection in a wild avian population. S Afr J Med Sci. 1968;33(4):105–112. [PubMed] [Google Scholar]
- [49].Buckley A, Dawson A, Moss SR, et al. Serological evidence of West Nile virus, Usutu virus and Sindbis virus infection of birds in the UK. J Gen Virol. 2003;84(10):2807–2817. doi: 10.1099/vir.0.19341-0 [DOI] [PubMed] [Google Scholar]
- [50].Francy DB, Jaenson TGT, Lundstrom JO, et al. Ecologic studies of mosquitos and birds as hosts of Ockelbo virus in Sweden and isolation of Inkoo and Batai viruses from mosquitos. Am J Trop Med Hyg. 1989;41(3):355–363. doi: 10.4269/ajtmh.1989.41.355 [DOI] [PubMed] [Google Scholar]
- [51].Hanafi-Bojd AA, Motazakker M, Vatandoost H, et al. Sindbis virus infection of mosquito species in the wetlands of northwestern Iran and modeling the probable ecological niches of SINV vectors in the country. Acta Trop. 2021;220:105952. doi: 10.1016/j.actatropica.2021.105952 [DOI] [PubMed] [Google Scholar]
- [52].Mohamed N, Magzoub M, Mohamed REH, et al. Prevalence and identification of arthropod-transmitted viruses in Kassala state, Eastern Sudan. Libyan J Med. 2019;14(1):1564511. doi: 10.1080/19932820.2018.1564511. PMC6366427 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [53].Weaver SC, Kang W, Shirako Y, et al. Recombinational history and molecular evolution of Western equine encephalomyelitis complex alphaviruses. J Virol. 1997;71(1):613–623. doi: 10.1128/jvi.71.1.613-623.1997. PMC191092 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [54].Suvanto MT, Uusitalo R, Otte Im Kampe E, et al. Sindbis virus outbreak and evidence for geographical expansion in Finland, 2021. Euro Surveill. 2022;27(31). doi: 10.2807/1560-7917.ES.2022.27.31.2200580. PMC9358406 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [55].Ahlm C, Eliasson M, Vapalahti O, et al. Seroprevalence of Sindbis virus and associated risk factors in northern Sweden. Epidemiol Infect. 2014;142(7):1559–1565. doi: 10.1017/S0950268813002239. PMC9167656 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [56].Shakya R, Tryland M, Vikse R, et al. Inkoo and Sindbis viruses in blood sucking insects, and a serological study for Inkoo virus in semi-domesticated Eurasian tundra reindeer in Norway. Virol J. 2022;19(1):99. doi: 10.1186/s12985-022-01815-0. PMC9166600 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [57].Kennedy N, Goedhals D, Vawda S, et al. Sindbis virus antibody seroprevalence in central plateau populations, South Africa. Emerg Infect Dis. 2022;28(10):2137–2139. doi: 10.3201/eid2810.211798. PMC9514352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [58].Lorenz C, Azevedo TS, Virginio F, et al. Impact of environmental factors on neglected emerging arboviral diseases. PLoS Negl Trop Dis. 2017;11(9):e0005959. doi: 10.1371/journal.pntd.0005959. PMC5633201 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [59].de Souza WM, Weaver SC. Effects of climate change and human activities on vector-borne diseases. Nat Rev Microbiol. 2024;22(8):476–491. doi: 10.1038/s41579-024-01026-0 [DOI] [PubMed] [Google Scholar]
- [60].Mora C, McKenzie T, Gaw IM, et al. Over half of known human pathogenic diseases can be aggravated by climate change. Nat Clim Change. 2022;12(9):869–875. doi: 10.1038/s41558-022-01426-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [61].Fong S-W, Kini RM, Ng LFP. Mosquito saliva reshapes alphavirus infection and immunopathogenesis. J Virol. 2018;92(12):1004–17. doi: 10.1128/JVI.01004-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [62].Johnson RT. Virus invasion of the central nervous system: a study of Sindbis virus infection in the mouse using fluorescent antibody. Am J Pathol. 1965;46:929–943. PMC1920389. [PMC free article] [PubMed] [Google Scholar]
- [63].Trgovcich J, Aronson JF, Johnston RE. Fatal Sindbis virus infection of neonatal mice in the absence of encephalitis. Virology. 1996;224(1):73–83. doi: 10.1006/viro.1996.0508 [DOI] [PubMed] [Google Scholar]
- [64].Sherman LA, Griffin DE. Pathogenesis of encephalitis induced in newborn mice by virulent and avirulent strains of Sindbis virus. J Virol. 1990;64(5):2041–2046. doi: 10.1128/jvi.64.5.2041-2046.1990. PMC249359 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [65].Heise MT, Simpson DA, Johnston RE. Sindbis-group alphavirus replication in periosteum and endosteum of long bones in adult mice. J Virol. 2000;74(19):9294–9299. doi: 10.1128/JVI.74.19.9294-9299.2000. PMC102128 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [66].Niklasson B, Espmark A, Lundstrom J. Occurrence of arthralgia and specific IgM antibodies 3 to 4 years after Ockelbo disease. J Infect Dis. 1988;157(4):832–835. doi: 10.1093/infdis/157.4.832 [DOI] [PubMed] [Google Scholar]
- [67].Levine B, Griffin DE. Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J Virol. 1992;66(11):6429–6435. doi: 10.1128/jvi.66.11.6429-6435.1992. PMC240135 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [68].Turunen M, Kuusisto P, Uggeldahl PE, et al. Pogosta disease: clinical observations during an outbreak in the province of North Karelia, Finland. Br J Rheumatol. 1998;37(11):1177–1180. doi: 10.1093/rheumatology/37.11.1177 [DOI] [PubMed] [Google Scholar]
- [69].Hörling J, Vene S, Franzén C, et al. Detection of Ockelbo virus RNA in skin biopsies by polymerase chain reaction. J Clin Microbiol. 1993;31(8):2004–2009. doi: 10.1128/jcm.31.8.2004-2009.1993. PMC265687 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [70].Laine M, Vainionpää R, Uksila J, et al. Prevalence of Sindbis-related (Pogosta) virus infections in patients with arthritis. Clin Exp Rheumatol. 2003;21(2):213–216. [PubMed] [Google Scholar]
- [71].Niklasson B, Espmark A. Ockelbo disease - arthralgia 3–4 years after infection with a Sindbis virus related agent. Lancet. 1986;327(8488):1039–1040. doi: 10.1016/S0140-6736(86)91315-2 [DOI] [PubMed] [Google Scholar]
- [72].Kurkela S, Helve T, Vaheri A, et al. Arthritis and arthralgia three years after Sindbis virus infection: clinical follow-up of a cohort of 49 patients. Scand J Infect Dis. 2008;40(2):167–173. doi: 10.1080/00365540701586996 [DOI] [PubMed] [Google Scholar]
- [73].Laine M, Luukkainen R, Jalava J, et al. Prolonged arthritis associated with Sindbis-related (Pogosta) virus infection. Rheumatol (Oxford). 2000;39(11):1272–1274. doi: 10.1093/rheumatology/39.11.1272 [DOI] [PubMed] [Google Scholar]
- [74].Labadie K, Larcher T, Joubert C, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest. 2010;120(3):894–906. doi: 10.1172/JCI40104. PMC2827953 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [75].Linn ML, Aaskov JG, Suhrbier A. Antibody-dependent enhancement and persistence in macrophages of an arbovirus associated with arthritis. J Gen Virol. 1996;77(3):407–411. doi: 10.1099/0022-1317-77-3-407 [DOI] [PubMed] [Google Scholar]
- [76].Sourisseau M, Schilte C, Casartelli N, et al. Characterization of reemerging chikungunya virus. PLoS Pathog. 2007;3(6):e89. doi: 10.1371/journal.ppat.0030089. PMC1904475 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [77].Guard RW, Mj M, Stallman ND, et al. Haemorrhagic manifestations with Sindbis infection. Case Report. Pathol. 1982;14(1):89–90. doi: 10.3109/00313028209069049 [DOI] [PubMed] [Google Scholar]
- [78].Sane J, Kurkela S, Lokki ML, et al. Clinical Sindbis alphavirus infection is associated with HLA-DRB1*01 allele and production of autoantibodies. Clin Infect Dis. 2012;55(3):358–363. doi: 10.1093/cid/cis405 [DOI] [PubMed] [Google Scholar]
- [79].Meno K, Yah C, Mendes A, et al. Incidence of Sindbis virus in hospitalized patients with acute fevers of unknown cause in South Africa, 2019–2020. Front Microbiol. 2021;12:798810. PMC8860305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [80].Woodson CM, Carney SK, Kehn-Hall K. Neuropathogenesis of encephalitic alphaviruses in non-human primate and mouse models of infection. Pathogens. 2025;14(2):193. doi: 10.3390/pathogens14020193. PMC11858634 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [81].Lidbury BA, Mahalingam S. Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection. J Virol. 2000;74(18):8376–8381. doi: 10.1128/JVI.74.18.8376-8381.2000. PMC116348 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [82].Morrison TE, Whitmore AC, Shabman RS, et al. Characterization of Ross River virus tropism and virus-induced inflammation in a mouse model of viral arthritis and myositis. J Virol. 2006;80(2):737–749. doi: 10.1128/JVI.80.2.737-749.2006. PMC1346871 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [83].Gardner J, Anraku I, Le TT, et al. Chikungunya virus arthritis in adult wild-type mice. J Virol. 2010;84(16):8021–8032. doi: 10.1128/JVI.02603-09. PMC2916516 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [84].Lidbury BA, Simeonovic C, Maxwell GE, et al. Macrophage-induced muscle pathology results in morbidity and mortality for Ross River virus-infected mice. J Infect Dis. 2000;181(1):27–34. doi: 10.1086/315164 [DOI] [PubMed] [Google Scholar]
- [85].Soden M, Vasudevan H, Roberts B, et al. Detection of viral ribonucleic acid and histologic analysis of inflamed synovium in Ross River virus infection. Arthritis Rheum. 2000;43(2):365–369. doi: 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E [DOI] [PubMed] [Google Scholar]
- [86].Hazelton RA, Hughes C, Aaskov JG. The inflammatory response in the synovium of a patient with Ross River arbovirus infection. Aust N Z J Med. 1985;15(3):336–339. doi: 10.1111/j.1445-5994.1985.tb04048.x [DOI] [PubMed] [Google Scholar]
- [87].Nakaya HI, Gardner J, Poo YS, et al. Gene profiling of Chikungunya virus arthritis in a mouse model reveals significant overlap with rheumatoid arthritis. Arthritis Rheum. 2012;64(11):3553–3563. doi: 10.1002/art.34631. PMC3836361 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [88].Sane J, Kurkela S, Desdouits M, et al. Prolonged myalgia in Sindbis virus infection: case description and in vitro infection of myotubes and myoblasts. J Infect Dis. 2012;206(3):407–414. doi: 10.1093/infdis/jis358 [DOI] [PubMed] [Google Scholar]
- [89].Herrero LJ, Nelson M, Srikiatkhachorn A, et al. Critical role for macrophage migration inhibitory factor (MIF) in Ross River virus-induced arthritis and myositis. In: Proceedings of the National Academy of Sciences of the United States of America; 2011. Vol. 108. p. 12048–12053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [90].Lidbury BA, Rulli NE, Suhrbier A, et al. Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus. J Infect Dis. 2008;197(11):1585–1593. doi: 10.1086/587841 [DOI] [PubMed] [Google Scholar]
- [91].Mateo L, La Linn M, McColl SR, et al. An arthrogenic alphavirus induces monocyte chemoattractant protein-1 and interleukin-8. Intervirology. 2000;43(1):55–60. doi: 10.1159/000025023 [DOI] [PubMed] [Google Scholar]
- [92].Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol. 2010;184(10):5914–5927. doi: 10.4049/jimmunol.0900255 [DOI] [PubMed] [Google Scholar]
- [93].Kumar S, Jaffar-Bandjee MC, Giry C, et al. Mouse macrophage innate immune response to Chikungunya virus infection. Virol J. 2012;9(1):313. doi: 10.1186/1743-422X-9-313. PMC3577478 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [94].Chow A, Her Z, Ong EK, et al. Persistent arthralgia induced by chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor. J Infect Dis. 2011;203(2):149–157. doi: 10.1093/infdis/jiq042. PMC3071069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [95].Patil DR, Hundekar SL, Arankalle VA. Expression profile of immune response genes during acute myopathy induced by chikungunya virus in a mouse model. Microbes Infect. 2012;14(5):457–469. doi: 10.1016/j.micinf.2011.12.008 [DOI] [PubMed] [Google Scholar]
- [96].Ng LF, Chow A, Sun YJ, et al. Il-1beta, il-6, and rantes as biomarkers of chikungunya severity. PLOS ONE. 2009;4(1):e4261. doi: 10.1371/journal.pone.0004261. PMC2625438 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [97].Chaaitanya IK, Muruganandam N, Sundaram SG, et al. Role of proinflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. Viral Immunol. 2011;24(4):265–271. doi: 10.1089/vim.2010.0123 [DOI] [PubMed] [Google Scholar]
- [98].Kelvin AA, Banner D, Silvi G, et al. Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis. 2011;5(8):e1279. doi: 10.1371/journal.pntd.0001279. PMC3156690 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [99].Assuncao-Miranda I, Bozza MT, Da Poian AT. Pro-inflammatory response resulting from Sindbis virus infection of human macrophages: implications for the pathogenesis of viral arthritis. J Med Virol. 2010;82(1):164–174. doi: 10.1002/jmv.21649 [DOI] [PubMed] [Google Scholar]
- [100].Chen W, Foo S-S, Sims NA, et al. Arthritogenic alphaviruses: new insights into arthritis and bone pathology. Trends Microbiol. 2015;23(1):35–43. doi: 10.1016/j.tim.2014.09.005 [DOI] [PubMed] [Google Scholar]
- [101].Rust NM, Papa MP, Scovino AM, et al. Bradykinin enhances Sindbis virus infection in human brain microvascular endothelial cells. Virology. 2012;422(1):81–91. doi: 10.1016/j.virol.2011.10.003 [DOI] [PubMed] [Google Scholar]
- [102].Xu J, Nash RJ, Frey TK. Cellular responses to Sindbis virus infection of neural progenitors derived from human embryonic stem cells. BMC Res Notes. 2014;7(1):757. doi: 10.1186/1756-0500-7-757. PMC4307679 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [103].LaPointe AT, Landers VD, Westcott CE, et al. Production of noncapped genomic RNAs is critical to Sindbis virus disease and pathogenicity. MBio. 2020;11(6). doi: 10.1128/mBio.02675-20. PMC7733944 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [104].Thach DC, Kimura T, Griffin DE. Differences between C57BL/6 and BALB/cBy mice in mortality and virus replication after intranasal infection with neuroadapted Sindbis virus. J Virol. 2000;74(13):6156–6161. doi: 10.1128/JVI.74.13.6156-6161.2000. PMC112114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [105].Thach DC, Kleeberger SR, Tucker PC, et al. Genetic control of neuroadapted sindbis virus replication in female mice maps to chromosome 2 and associates with paralysis and mortality. J Virol. 2001;75(18):8674–8680. doi: 10.1128/JVI.75.18.8674-8680.2001. PMC115112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [106].Dubuisson J, Lustig S, Ruggli N, et al. Genetic determinants of Sindbis virus neuroinvasiveness. J Virol. 1997;71(4):2636–2646. doi: 10.1128/jvi.71.4.2636-2646.1997. PMC191385 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [107].Ben-Nathan D, Lustig S, Danenberg HD. Stress-induced neuroinvasiveness of a neurovirulent noninvasive Sindbis virus in cold or isolation subjected mice. Life Sci. 1991;48(15):1493–1500. doi: 10.1016/0024-3205(91)90187-G [DOI] [PubMed] [Google Scholar]
- [108].Irani DN, Griffin DE. Regulation of lymphocyte homing into the brain during viral encephalitis at various stages of infection. J Immunol (Baltim, Md: 1950). 1996;156(10):3850–3857. doi: 10.4049/jimmunol.156.10.3850 [DOI] [PubMed] [Google Scholar]
- [109].Lee EY, Schultz KL, Griffin DE. Mice deficient in interferon-gamma or interferon-gamma receptor 1 have distinct inflammatory responses to acute viral encephalomyelitis. PLOS ONE. 2013;8(10):e76412. doi: 10.1371/journal.pone.0076412. PMC3811984 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [110].Passoni G, Langevin C, Palha N, et al. Imaging of viral neuroinvasion in the zebrafish reveals that Sindbis and chikungunya viruses favour different entry routes. Dis Model Mech. 2017;10:847–857. doi: 10.1242/dmm.029231. PMC5536907 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [111].Moench TR, Griffin DE. Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis. J Exp Med. 1984;159(1):77–88. doi: 10.1084/jem.159.1.77 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [112].Baxter VK, Troisi EM, Pate NM, et al. Death and gastrointestinal bleeding complicate encephalomyelitis in mice with delayed appearance of CNS IgM after intranasal alphavirus infection. J Gen Virol. 2018;99(3):309–320. doi: 10.1099/jgv.0.001005. PMC5891226 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [113].Kimura T, Griffin DE. Extensive immune-mediated hippocampal damage in mice surviving infection with neuroadapted Sindbis virus. Virology. 2003;311(1):28–39. doi: 10.1016/S0042-6822(03)00110-7 [DOI] [PubMed] [Google Scholar]
- [114].Irani DN, Prow NA. Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis. J Neuropathol Exp Neurol. 2007;66(6):533–544. doi: 10.1097/01.jnen.0000263867.46070.e2. PMC3143496 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [115].Irani DN, Griffin DE. Isolation of brain parenchymal lymphocytes for flow cytometric analysis: application to acute viral encephalitis. J Immunol Methods. 1991;139(2):223–231. doi: 10.1016/0022-1759(91)90192-I [DOI] [PubMed] [Google Scholar]
- [116].Griffin DE. Role of the immune response in age-dependent resistance of mice to encephalitis due to Sindbis virus. J Infect Dis. 1976;133(4):456–464. doi: 10.1093/infdis/133.4.456 [DOI] [PubMed] [Google Scholar]
- [117].Levine B, Hardwick JM, Trapp BD, et al. Antibody-mediated clearance of alphavirus infection from neurons. Science. 1991;254(5033):856–860. doi: 10.1126/science.1658936 [DOI] [PubMed] [Google Scholar]
- [118].Wesselingh SL, Levine B, Fox RJ, et al. Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response. J Immunol. 1994;152(3):1289–1297. doi: 10.4049/jimmunol.152.3.1289 [DOI] [PubMed] [Google Scholar]
- [119].Kimura T, Griffin DE. The role of CD8(+) T cells and major histocompatibility complex class I expression in the central nervous system of mice infected with neurovirulent Sindbis virus. J Virol. 2000;74(13):6117–6125. doi: 10.1128/JVI.74.13.6117-6125.2000. PMC112110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [120].Rowell JF, Griffin DE. Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis. J Neuroimmunol. 2002;127(1–2):106–114. doi: 10.1016/S0165-5728(02)00108-X [DOI] [PubMed] [Google Scholar]
- [121].Kulcsar KA, Baxter VK, Greene IP, et al. Interleukin 10 modulation of pathogenic Th17 cells during fatal alphavirus encephalomyelitis. Proc Natl Acad Sci USA. 2014;111(45):16053–16058. doi: 10.1073/pnas.1418966111. PMC4234572 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [122].Kulcsar KA, Baxter VK, Abraham R, et al. Distinct immune responses in resistant and susceptible strains of mice during neurovirulent alphavirus encephalomyelitis. J Virol. 2015;89(16):8280–8291. doi: 10.1128/JVI.00173-15. PMC4524229 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [123].Kulcsar KA, Griffin DE. T cell-derived interleukin-10 is an important regulator of the Th17 response during lethal alphavirus encephalomyelitis. J Neuroimmunol. 2016;295–296:60–67. doi: 10.1016/j.jneuroim.2016.04.010. PMC4884611 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [124].Martin NM, Griffin DE. Interleukin-10 modulation of virus clearance and disease in mice with alphaviral encephalomyelitis. J Virol. 2018;92(6). doi: 10.1128/JVI.01517-17. PMC5827374 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [125].Rowell JF, Griffin DE. The inflammatory response to nonfatal Sindbis virus infection of the nervous system is more severe in SJL than in BALB/c mice and is associated with low levels of IL-4 mRNA and high levels of IL-10-producing CD4+ T cells. J Immunol. 1999;162(3):1624–1632. doi: 10.4049/jimmunol.162.3.1624 [DOI] [PubMed] [Google Scholar]
- [126].Baxter VK, Griffin DE. Interferon gamma modulation of disease manifestation and the local antibody response to alphavirus encephalomyelitis. J Gen Virol. 2016;97(11):2908–2925. doi: 10.1099/jgv.0.000613. PMC5770845 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [127].Baxter VK, Troisi EM, Pate NM, et al. Corrigendum: death and gastrointestinal bleeding complicate encephalomyelitis in mice with delayed appearance of CNS IgM after intranasal alphavirus infection. J Gen Virol. 2018;99(5):759. doi: 10.1099/jgv.0.001062. PMC6537623 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [128].Ryman KD, Klimstra WB, Nguyen KB, et al. Alpha/beta interferon protects adult mice from fatal Sindbis virus infection and is an important determinant of cell and tissue tropism. J Virol. 2000;74(7):3366–3378. doi: 10.1128/JVI.74.7.3366-3378.2000. PMC111838 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [129].Sarid R, Ben-Moshe T, Kazimirsky G, et al. vFLIP protects PC-12 cells from apoptosis induced by Sindbis virus: implications for the role of TNF-alpha. Cell Death Differ. 2001;8(12):1224–1231. doi: 10.1038/sj.cdd.4400926 [DOI] [PubMed] [Google Scholar]
- [130].Carmen J, Rothstein JD, Kerr DA. Tumor necrosis factor-alpha modulates glutamate transport in the CNS and is a critical determinant of outcome from viral encephalomyelitis. Brain Res. 2009;1263:143–154. PMC2952353. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [131].Prow NA, Irani DN. The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis. Exp Neurol. 2007;205(2):461–470. doi: 10.1016/j.expneurol.2007.03.013. PMC1939803 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [132].Prow NA, Irani DN. The inflammatory cytokine, interleukin-1 beta, mediates loss of astroglial glutamate transport and drives excitotoxic motor neuron injury in the spinal cord during acute viral encephalomyelitis. J Neurochem. 2008;105(4):1276–1286. doi: 10.1111/j.1471-4159.2008.05230.x. PMC2579753 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [133].Eberly AR. Medically important alphaviruses in the United States and how to test for them. Clin Microbiol Newsl. 2024;49:28–36. doi: 10.1016/j.clinmicnews.2024.10.003 [DOI] [Google Scholar]
- [134].Calisher CH, Meurman O, Brummerkorvenkontio M, et al. Sensitive enzyme-immunoassay for detecting immunoglobulin-M antibodies to Sindbis virus and further evidence that Pogosta disease is caused by a Western equine encephalitis complex virus. J Clin Microbiol. 1985;22(4):566–571. doi: 10.1128/jcm.22.4.566-571.1985 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [135].Sane J, Kurkela S, Levanov L, et al. Development and evaluation of a real-time RT-PCR assay for Sindbis virus detection. J Virol Methods. 2012;179(1):185–188. doi: 10.1016/j.jviromet.2011.10.021 [DOI] [PubMed] [Google Scholar]
- [136].Jones A, Doherty M. Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response. Ann Rheum Dis. 1996;55(11):829–832. doi: 10.1136/ard.55.11.829. PMC1010319 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [137].Taylor A, Sheng KC, Herrero LJ, et al. Methotrexate treatment causes early onset of disease in a mouse model of Ross River virus-induced inflammatory disease through increased monocyte production. PLOS ONE. 2013;8(8):e71146. doi: 10.1371/journal.pone.0071146. PMC3741301 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [138].Tan YB, Chmielewski D, Law MCY, et al. Molecular architecture of the chikungunya virus replication complex. Sci Adv. 2022;8(48):eadd2536. doi: 10.1126/sciadv.add2536 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [139].Klimstra WB, Ryman KD, Johnston RE. Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol. 1998;72(9):7357–7366. doi: 10.1128/JVI.72.9.7357-7366.1998. PMC109960 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [140].Ryman KD, Gardner CL, Burke CW, et al. Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J Virol. 2007;81(7):3563–3573. doi: 10.1128/JVI.02494-06. PMC1866052 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [141].Klimstra WB, Nangle EM, Smith MS, et al. Dc-sign and L-sign can act as attachment receptors for alphaviruses and distinguish between mosquito cell- and mammalian cell-derived viruses. J Virol. 2003;77(22):12022–12032. doi: 10.1128/JVI.77.22.12022-12032.2003. PMC254289 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [142].Rose PP, Hanna SL, Spiridigliozzi A, et al. Natural resistance-associated macrophage protein is a cellular receptor for Sindbis virus in both insect and mammalian hosts. Cell Host Microbe. 2011;10(2):97–104. doi: 10.1016/j.chom.2011.06.009. PMC3164510 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [143].Wang KS, Kuhn RJ, Strauss EG, et al. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol. 1992;66(8):4992–5001. doi: 10.1128/jvi.66.8.4992-5001.1992. PMC241351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [144].Zimmerman O, Zimmerman MI, Raju S, et al. Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8. Cell. 2023;186(22):4818–4833.e25. doi: 10.1016/j.cell.2023.09.007. PMC10615782 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [145].Clark LE, Clark SA, Lin C, et al. VLDLR and ApoER2 are receptors for multiple alphaviruses. Nature. 2022;602(7897):475–480. doi: 10.1038/s41586-021-04326-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [146].Kielian M, Chanel-Vos C, Liao M. Alphavirus entry and membrane fusion. Viruses. 2010;2(4):796–825. doi: 10.3390/v2040796. PMC3086016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [147].Helenius A, Kartenbeck J, Simons K, et al. On the entry of Semliki Forest virus into BHK-21 cells. J Cell Biol. 1980;84(2):404–420. doi: 10.1083/jcb.84.2.404. PMC2110562 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [148].Helenius A. Semliki Forest virus penetration from endosomes: a morphological study. Biol Cell. 1984;51(2):181–185. doi: 10.1111/j.1768-322X.1984.tb00297.x [DOI] [PubMed] [Google Scholar]
- [149].Froshauer S, Kartenbeck J, Helenius A. Alphavirus RNA replicase is located on the cytoplasmic surface of endosomes and lysosomes. J Cell Biol. 1988;107(6):2075–2086. doi: 10.1083/jcb.107.6.2075. PMC2115628 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [150].Schmid S, Fuchs R, Kielian M, et al. Acidification of endosome subpopulations in wild-type Chinese hamster ovary cells and temperature-sensitive acidification-defective mutants. J Cell Biol. 1989;108(4):1291–1300. doi: 10.1083/jcb.108.4.1291. PMC2115517 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [151].Choi HK, Tong L, Minor W, et al. Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature. 1991;354(6348):37–43. doi: 10.1038/354037a0 [DOI] [PubMed] [Google Scholar]
- [152].Mukhopadhyay S, Chipman PR, Hong EM, et al. In vitro-assembled alphavirus core-like particles maintain a structure similar to that of nucleocapsid cores in mature virus. J Virol. 2002;76(21):11128–11132. doi: 10.1128/JVI.76.21.11128-11132.2002. PMC136650 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [153].Sokoloski KJ, Snyder AJ, Liu NH, et al. Encapsidation of host-derived factors correlates with enhanced infectivity of Sindbis virus. J Virol. 2013;87(22):12216–12226. doi: 10.1128/JVI.02437-13. PMC3807880 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [154].Mackenzie-Liu D, Sokoloski KJ, Purdy S, et al. Encapsidated host factors in alphavirus particles influence midgut infection of Aedes aegypti. Viruses. 2018;10(5):263. doi: 10.3390/v10050263. PMC5977256 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [155].Wengler G, Gros C, Wengler G. Analyses of the role of structural changes in the regulation of uncoating and assembly of alphavirus cores. Virology. 1996;222(1):123–132. doi: 10.1006/viro.1996.0403 [DOI] [PubMed] [Google Scholar]
- [156].Wengler G, Koschinski A, Wengler G, et al. Entry of alphaviruses at the plasma membrane converts the viral surface proteins into an ion-permeable pore that can be detected by electrophysiological analyses of whole-cell membrane currents. J Gen Virol. 2003;84(1):173–181. doi: 10.1099/vir.0.18696-0. PMC515398 [DOI] [PubMed] [Google Scholar]
- [157].Hefti E, Bishop DH, Dubin DT, et al. 5’ nucleotide sequence of Sindbis viral RNA. J Virol. 1975;17(1):149–159. doi: 10.1128/jvi.17.1.149-159.1976. PMC515398 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [158].Strauss EG, Rice CM, Strauss JH. Sequence coding for the alphavirus nonstructural proteins is interrupted by an opal termination codon. Proc Natl Acad Sci USA. 1983;80(17):5271–5275. doi: 10.1073/pnas.80.17.5271. PMC384235 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [159].Li G, Rice CM. The signal for translational readthrough of a UGA codon in Sindbis virus RNA involves a single cytidine residue immediately downstream of the termination codon. J Virol. 1993;67(8):5062–5067. doi: 10.1128/jvi.67.8.5062-5067.1993. PMC237898 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [160].Shirako Y, Strauss JH. Regulation of Sindbis virus RNA replication: uncleaved P123 and nsP4 function in minus-strand RNA synthesis, whereas cleaved products from P123 are required for efficient plus-strand RNA synthesis. J Virol. 1994;68(3):1874–1885. doi: 10.1128/jvi.68.3.1874-1885.1994. PMC236650 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [161].Hardy WR, Strauss JH. Processing the nonstructural polyproteins of sindbis virus: nonstructural proteinase is in the C-terminal half of nsP2 and functions both in cis and in trans. J Virol. 1989;63(11):4653–4664. doi: 10.1128/jvi.63.11.4653-4664.1989. PMC251099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [162].Gorchakov R, Frolova E, Sawicki S, et al. A new role for NS polyprotein cleavage in Sindbis virus replication. J Virol. 2008;82(13):6218–6231. doi: 10.1128/JVI.02624-07. PMC2447110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [163].Lemm JA, Rice CM. Roles of nonstructural polyproteins and cleavage products in regulating Sindbis virus RNA replication and transcription. J Virol. 1993;67(4):1916–1926. doi: 10.1128/jvi.67.4.1916-1926.1993. PMC240259 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [164].Lemm JA, Rice CM. Assembly of functional Sindbis virus RNA replication complexes: requirement for coexpression of P123 and P34. J Virol. 1993;67(4):1905–1915. doi: 10.1128/jvi.67.4.1905-1915.1993. PMC240258 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [165].Sawicki DL, Sawicki SG. Alphavirus positive and negative strand RNA synthesis and the role of polyproteins in formation of viral replication complexes. Arch Virol Suppl. 1994;9:393–405. [DOI] [PubMed] [Google Scholar]
- [166].Lemm JA, Bergqvist A, Read CM, et al. Template-dependent initiation of Sindbis virus RNA replication in vitro. J Virol. 1998;72(8):6546–6553. doi: 10.1128/JVI.72.8.6546-6553.1998. PMC109826 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [167].Lemm JA, Rumenapf T, Strauss EG, et al. Polypeptide requirements for assembly of functional Sindbis virus replication complexes: a model for the temporal regulation of minus- and plus-strand RNA synthesis. Embo J. 1994;13(12):2925–2934. doi: 10.1002/j.1460-2075.1994.tb06587.x. PMC395174 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [168].Hardy WR, Hahn YS, de Groot RJ, et al. Synthesis and processing of the nonstructural polyproteins of several temperature-sensitive mutants of Sindbis virus. Virology. 1990;177(1):199–208. doi: 10.1016/0042-6822(90)90473-5 [DOI] [PubMed] [Google Scholar]
- [169].Ahola T, McInerney G, Merits A. Chapter four - Alphavirus RNA replication in vertebrate cells. In: Kielian M, Mettenleiter TRoossinck M, editors. Advances in virus research. Vol. 111. Academic Press; 2021. p 111–156. [DOI] [PubMed] [Google Scholar]
- [170].Skidmore AM, Bradfute SB. The life cycle of the alphaviruses: from an antiviral perspective. Antiviral Res. 2023;209:105476. doi: 10.1016/j.antiviral.2022.105476 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [171].Rupp JC, Sokoloski KJ, Gebhart NN, et al. Alphavirus RNA synthesis and non-structural protein functions. J Gen Virol. 2015;96(9):2483–2500. doi: 10.1099/jgv.0.000249. PMC4635493 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [172].Lemaire PA, Anderson E, Lary J, et al. Mechanism of PKR activation by dsRNA. J Mol Biol. 2008;381(2):351–360. doi: 10.1016/j.jmb.2008.05.056. PMC2570377 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [173].Toribio R, Díaz-López I, Berlanga JJ, et al. Naturally occurring and engineered alphaviruses sensitive to double-stranded-RNA-activated protein kinase show restricted translation in mammalian cells, increased sensitivity to interferon, and marked oncotropism. J Virol. 2020;94(3). doi: 10.1128/JVI.01630-19. PMC7000984 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [174].Ventoso I, Sanz MA, Molina S, et al. Translational resistance of late alphavirus mRNA to eIF2alpha phosphorylation: a strategy to overcome the antiviral effect of protein kinase PKR. Genes Dev. 2006;20(1):87–100. doi: 10.1101/gad.357006. PMC1356103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [175].Garmashova N, Gorchakov R, Volkova E, et al. The old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff. J Virol. 2007;81(5):2472–2484. doi: 10.1128/JVI.02073-06. PMC1865960 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [176].Patel RK, Burnham AJ, Gebhart NN, et al. Role for subgenomic mRNA in host translation inhibition during Sindbis virus infection of mammalian cells. Virology. 2013;441(2):171–181. doi: 10.1016/j.virol.2013.03.022. PMC3660432 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [177].Mudiganti U, Hernandez R, Brown DT. Insect response to alphavirus infection–establishment of alphavirus persistence in insect cells involves inhibition of viral polyprotein cleavage. Virus Res. 2010;150(1–2):73–84. doi: 10.1016/j.virusres.2010.02.016 [DOI] [PubMed] [Google Scholar]
- [178].Frolova EI, Gorchakov R, Pereboeva L, et al. Functional Sindbis virus replicative complexes are formed at the plasma membrane. J Virol. 2010;84(22):11679–11695. doi: 10.1128/JVI.01441-10. PMC2977861 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [179].Friedman RM, Levin JG, Grimley PM, et al. Membrane-associated replication complex in arbovirus infection. J Virol. 1972;10(3):504–515. doi: 10.1128/jvi.10.3.504-515.1972. PMC356492 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [180].Spuul P, Balistreri G, Hellström K, et al. Assembly of alphavirus replication complexes from RNA and protein components in a novel trans-replication system in mammalian cells. J Virol. 2011;85(10):4739–4751. doi: 10.1128/JVI.00085-11. PMC3126202 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [181].Grimley PM, Berezesky IK, Friedman RM. Cytoplasmic structures associated with an arbovirus infection: loci of viral ribonucleic acid synthesis. J Virol. 1968;2(11):1326–1338. doi: 10.1128/jvi.2.11.1326-1338.1968. PMC375472 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [182].Grimley PM, Levin JG, Berezesky IK, et al. Specific membranous structures associated with the replication of group A arboviruses. J Virol. 1972;10(3):492–503. doi: 10.1128/jvi.10.3.492-503.1972. PMC356491 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [183].Salonen A, Ahola T, Kääriäinen L. Viral RNA replication in association with cellular membranes. Curr Top Microbiol Immunol. 2005;285:139–173. PMC7120253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [184].Jose J, Taylor AB, Kuhn RJ. Spatial and temporal analysis of alphavirus replication and assembly in mammalian and mosquito cells. MBio. 2017;8(1). doi: 10.1128/mBio.02294-16. PMC5312085 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [185].Hellstrom K, Kallio K, Utt A, et al. Partially uncleaved alphavirus replicase forms spherule structures in the presence and absence of RNA template. J Virol. 2017;91(18). doi: 10.1128/JVI.00787-17. PMC5571266 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [186].Kallio K, Hellström K, Jokitalo E, et al. Rna replication and membrane modification require the same functions of alphavirus nonstructural proteins. J Virol. 2016;90(3):1687–1692. doi: 10.1128/JVI.02484-15. PMC4719637 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [187].Utt A, Quirin T, Saul S, et al. Versatile trans-replication systems for Chikungunya virus allow functional analysis and tagging of every replicase protein. PLOS ONE. 2016;11(3):e0151616. doi: 10.1371/journal.pone.0151616. PMC4786200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [188].Thaa B, Biasiotto R, Eng K, et al. Correction for Thaa et al. differential phosphatidylinositol-3-kinase-Akt-mTOR activation by Semliki Forest and Chikungunya viruses is dependent on nsP3 and connected to replication complex internalization. J Virol. 2016;90:4256. PMC4810537. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [189].Thaa B, Biasiotto R, Eng K, et al. Differential phosphatidylinositol-3-kinase-Akt-mTOR activation by Semliki Forest and Chikungunya viruses is dependent on nsP3 and connected to replication complex internalization. J Virol. 2015;89(22):11420–11437. doi: 10.1128/JVI.01579-15. PMC4645633 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [190].Spuul P, Balistreri G, Kääriäinen L, et al. Phosphatidylinositol 3-kinase-, actin-, and microtubule-dependent transport of Semliki Forest virus replication complexes from the plasma membrane to modified lysosomes. J Virol. 2010;84(15):7543–7557. doi: 10.1128/JVI.00477-10. PMC2897599 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [191].Jose J, Snyder JE, Kuhn RJ. A structural and functional perspective of alphavirus replication and assembly. Future Microbiol. 2009;4(7):837–856. doi: 10.2217/fmb.09.59. PMC2762864 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [192].Thomas S, Rai J, John L, et al. Functional dissection of the alphavirus capsid protease: sequence requirements for activity. Virol J. 2010;7(1):327. doi: 10.1186/1743-422X-7-327. PMC2999604 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [193].Garoff H, Huylebroeck D, Robinson A, et al. The signal sequence of the p62 protein of Semliki Forest virus is involved in initiation but not in completing chain translocation. J Cell Biol. 1990;111(3):867–876. doi: 10.1083/jcb.111.3.867. PMC2116283 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [194].Bonatti S, Blobel G. Absence of a cleavable signal sequence in Sindbis virus glycoprotein pe2. J Biol Chem. 1979;254(24):12261–12264. doi: 10.1016/S0021-9258(19)86303-2 [DOI] [PubMed] [Google Scholar]
- [195].Bonatti S, Migliaccio G, Blobel G, et al. Role of signal recognition particle in the membrane assembly of Sindbis viral glycoproteins. Eur J Biochem. 1984;140(3):499–502. doi: 10.1111/j.1432-1033.1984.tb08130.x [DOI] [PubMed] [Google Scholar]
- [196].Liljeström P, Garoff H. Internally located cleavable signal sequences direct the formation of Semliki Forest virus membrane proteins from a polyprotein precursor. J Virol. 1991;65(1):147–154. doi: 10.1128/jvi.65.1.147-154.1991. PMC240499 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [197].Zhang X, Fugëre M, Day R, et al. Furin processing and proteolytic activation of Semliki Forest virus. J Virol. 2003;77(5):2981–2989. doi: 10.1128/JVI.77.5.2981-2989.2003. PMC149766 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [198].de Curtis I, Simons K. Dissection of Semliki Forest virus glycoprotein delivery from the trans-Golgi network to the cell surface in permeabilized BHK cells. Proc Natl Acad Sci USA. 1988;85(21):8052–8056. doi: 10.1073/pnas.85.21.8052. PMC282352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [199].Paredes AM, Heidner H, Thuman-Commike P, et al. Structural localization of the E3 glycoprotein in attenuated Sindbis virus mutants. J Virol. 1998;72(2):1534–1541. doi: 10.1128/JVI.72.2.1534-1541.1998. PMC124635 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [200].Firth AE, Chung BY, Fleeton MN, et al. Discovery of frameshifting in alphavirus 6K resolves a 20-year enigma. Virol J. 2008;5(1):108. doi: 10.1186/1743-422X-5-108. PMC2569925 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [201].Chung BY, Firth AE, Atkins JF. Frameshifting in alphaviruses: a diversity of 3’ stimulatory structures. J Mol Biol. 2010;397(2):448–456. doi: 10.1016/j.jmb.2010.01.044 [DOI] [PubMed] [Google Scholar]
- [202].Antoine AF, Montpellier C, Cailliau K, et al. The alphavirus 6K protein activates endogenous ionic conductances when expressed in Xenopus oocytes. J Membr Biol. 2007;215(1):37–48. doi: 10.1007/s00232-007-9003-6 [DOI] [PubMed] [Google Scholar]
- [203].Melton JV, Ewart GD, Weir RC, et al. Alphavirus 6K proteins form ion channels*. J Biol Chem. 2002;277(49):46923–46931. doi: 10.1074/jbc.M207847200 [DOI] [PubMed] [Google Scholar]
- [204].Elmasri Z, Negi V, Kuhn RJ, et al. Requirement of a functional ion channel for Sindbis virus glycoprotein transport, CPV-II formation, and efficient virus budding. PLoS Pathog. 2022;18(10):e1010892. doi: 10.1371/journal.ppat.1010892. PMC9560593 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [205].Snyder JE, Kulcsar KA, Schultz KL, et al. Functional characterization of the alphavirus TF protein. J Virol. 2013;87(15):8511–8523. doi: 10.1128/JVI.00449-13. PMC3719798 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [206].Rogers KJ, Jones-Burrage S, Maury W, et al. Tf protein of Sindbis virus antagonizes host type I interferon responses in a palmitoylation-dependent manner. Virology. 2020;542:63–70. doi: 10.1016/j.virol.2020.01.001. PMC7024065 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [207].Ramsey J, Renzi EC, Arnold RJ, et al. Palmitoylation of Sindbis virus TF protein regulates its plasma membrane localization and subsequent incorporation into virions. J Virol. 2017;91(3). doi: 10.1128/JVI.02000-16. PMC5244351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [208].Ramsey J, Chavez M, Mukhopadhyay S. Domains of the TF protein important in regulating its own palmitoylation. Virology. 2019;531:31–39. doi: 10.1016/j.virol.2019.02.016. PMC6486417 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [209].Mendes A, Kuhn RJ. Alphavirus nucleocapsid packaging and assembly. Viruses. 2018;10(3):138. doi: 10.3390/v10030138. PMC5869531 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [210].Weiss B, Nitschko H, Ghattas I, et al. Evidence for specificity in the encapsidation of Sindbis virus RNAs. J Virol. 1989;63(12):5310–5318. doi: 10.1128/jvi.63.12.5310-5318.1989. PMC251197 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [211].Geigenmüller-Gnirke U, Nitschko H, Schlesinger S. Deletion analysis of the capsid protein of Sindbis virus: identification of the RNA binding region. J Virol. 1993;67(3):1620–1626. doi: 10.1128/jvi.67.3.1620-1626.1993. PMC237533 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [212].Frolova E, Frolov I, Schlesinger S. Packaging signals in alphaviruses. J Virol. 1997;71(1):248–258. doi: 10.1128/jvi.71.1.248-258.1997. PMC191045 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [213].Kim DY, Firth AE, Atasheva S, et al. Conservation of a packaging signal and the viral genome RNA packaging mechanism in alphavirus evolution. J Virol. 2011;85(16):8022–8036. doi: 10.1128/JVI.00644-11. PMC3147971 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [214].Suomalainen M, Liljeström P, Garoff H. Spike protein-nucleocapsid interactions drive the budding of alphaviruses. J Virol. 1992;66(8):4737–4747. doi: 10.1128/jvi.66.8.4737-4747.1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [215].Jose J, Przybyla L, Edwards TJ, et al. Interactions of the cytoplasmic domain of Sindbis virus E2 with nucleocapsid cores promote alphavirus budding. J Virol. 2012;86(5):2585–2599. doi: 10.1128/JVI.05860-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [216].Zhao H, Lindqvist B, Garoff H, et al. A tyrosine-based motif in the cytoplasmic domain of the alphavirus envelope protein is essential for budding. Embo J. 1994;13(18):4204–4211. doi: 10.1002/j.1460-2075.1994.tb06740.x. PMC395347 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [217].Soonsawad P, Xing L, Milla E, et al. Structural evidence of glycoprotein assembly in cellular membrane compartments prior to alphavirus budding. J Virol. 2010;84(21):11145–11151. doi: 10.1128/JVI.00036-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [218].Martinez MG, Kielian M. Intercellular extensions are induced by the alphavirus structural proteins and mediate virus transmission. PLoS Pathog. 2016;12(12):e1006061. doi: 10.1371/journal.ppat.1006061 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [219].Klimstra WB, Ryman KD, Bernard KA, et al. Infection of neonatal mice with Sindbis virus results in a systemic inflammatory response syndrome. J Virol. 1999;73(12):10387–10398. doi: 10.1128/JVI.73.12.10387-10398.1999. PMC113094 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [220].McKnight KL, Simpson DA, Lin S-C, et al. Deduced consensus sequence of Sindbis virus strain AR339: mutations contained in laboratory strains which affect cell culture and in vivo phenotypes. J Virol. 1996;70(3):1981–1989. doi: 10.1128/jvi.70.3.1981-1989.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [221].Johnson RT, McFarland HF, Levy SE. Age-dependent resistance to viral encephalitis: studies of infections due to Sindbis virus in mice. J Infect Dis. 1972;125(3):257–262. doi: 10.1093/infdis/125.3.257 [DOI] [PubMed] [Google Scholar]
- [222].Levine B, Hardwick JM, Trapp BD, et al. Neuroadaptation of Sindbis virus: the development of variants with increased neurovirulence. J Virol. 1976;17(2):462–470. doi: 10.1128/JVI.17.2.462-471.1976 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [223].Rice CM, Levis R, Strauss JH, et al. Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. J Virol. 1987;61(12):3809–3819. doi: 10.1128/jvi.61.12.3809-3819.1987. PMC255997 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [224].Polo JM, Davis NL, Rice CM, et al. Molecular analysis of Sindbis virus pathogenesis in neonatal mice by using virus recombinants constructed in vitro. J Virol. 1988;62(6):2124–2133. doi: 10.1128/jvi.62.6.2124-2133.1988. PMC253309 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [225].Lustig S, Jackson AC, Hahn CS, et al. Molecular basis of Sindbis virus neurovirulence in mice. J Virol. 1988;62(7):2329–2336. doi: 10.1128/jvi.62.7.2329-2336.1988. PMC253389 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [226].Lustig S, Halevy M, Ben-Nathan D, et al. A novel variant of Sindbis virus is both neurovirulent and neuroinvasive in adult mice. Arch Virol. 1992;122(3–4):237–248. doi: 10.1007/BF01317186 [DOI] [PubMed] [Google Scholar]
- [227].Johnston RE, Peters CJ. Ar86: a virulent strain of Sindbis virus isolated from mosquitoes in Egypt. J Virol. 1984;50:81–87. [Google Scholar]
- [228].McIntosh BM, Worth CB, Kokernot RH. Arthropod-borne virus infections in man in South Africa: serological survey in the Girdwood area. S Afr Med J. 1961;35:647–652.13774006 [Google Scholar]
- [229].Suthar MS, Shabman R, Madric K, et al. Identification of adult mouse neurovirulence determinants of the Sindbis virus strain AR86. J Virol. 2005;79(7):4219–4228. doi: 10.1128/JVI.79.7.4219-4228.2005. PMC1061553 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [230].Stanley J, Cooper SJ, Griffin DE. Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus. J Virol. 1985;56(1):110–119. doi: 10.1128/jvi.56.1.110-119.1985 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [231].Lee S, Owen KE, Choi HK, et al. Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly. Structure. 1996;4(5):531–541. doi: 10.1016/S0969-2126(96)00059-7 [DOI] [PubMed] [Google Scholar]
- [232].Skoging U, Vihinen M, Nilsson L, et al. Aromatic interactions define the binding of the alphavirus spike to its nucleocapsid. Structure. 1996;4(5):519–529. doi: 10.1016/S0969-2126(96)00058-5 [DOI] [PubMed] [Google Scholar]
- [233].Wilkinson TA, Tellinghuisen TL, Kuhn RJ, et al. Association of Sindbis virus capsid protein with phospholipid membranes and the E2 glycoprotein: implications for alphavirus assembly. Biochemistry. 2005;44(8):2800–2810. doi: 10.1021/bi0479961 [DOI] [PubMed] [Google Scholar]
- [234].Kielian M. Membrane fusion and the alphavirus life cycle. Adv Virus Res. 1995;45:113–151. [DOI] [PubMed] [Google Scholar]
- [235].White J, Helenius A. pH-dependent fusion between the Semliki Forest virus membrane and liposomes. Proc Natl Acad Sci U S A. 1980;77(6):3273–3277. doi: 10.1073/pnas.77.6.3273. PMC349597 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [236].Li L, Jose J, Xiang Y, et al. Structural changes of envelope proteins during alphavirus fusion. Nature. 2010;468(7324):705–708. doi: 10.1038/nature09546. PMC3057476 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [237].Dropulic LK, Hardwick JM, Griffin DE. A single amino acid change in the E2 glycoprotein of Sindbis virus confers neurovirulence by altering an early step of virus replication. J Virol. 1997;71(8):6100–6105. doi: 10.1128/jvi.71.8.6100-6105.1997. PMC191870 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [238].Levine B, Griffin DE. Molecular analysis of neurovirulent strains of Sindbis virus that evolve during persistent infection of SCID mice. J Virol. 1993;67(11):6872–6875. doi: 10.1128/jvi.67.11.6872-6875.1993 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [239].Tucker PC, Lee SH, Bui N, et al. Amino acid changes in the Sindbis virus E2 glycoprotein that increase neurovirulence improve entry into neuroblastoma cells. J Virol. 1997;71(8):6106–6112. doi: 10.1128/jvi.71.8.6106-6112.1997. PMC191871 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [240].Lee P, Knight R, Smit JM, et al. A single mutation in the E2 glycoprotein important for neurovirulence influences binding of Sindbis virus to neuroblastoma cells. J Virol. 2002;76(12):6302–6310. doi: 10.1128/JVI.76.12.6302-631-.2002. PMC136218 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [241].Zhu W, Deng L, Wei Y, et al. A substitution in nsp1 combined with a double substitution in E2 glycoprotein renders Sindbis-like virus XJ-160 fully neurovirulent for adult mice. Virus Res. 2015;196:1–4. doi: 10.1016/j.virusres.2014.10.027 [DOI] [PubMed] [Google Scholar]
- [242].Johnston C, Jiang W, Chu T, et al. Identification of genes involved in the host response to neurovirulent alphavirus infection. J Virol. 2001;75(21):10431–10445. doi: 10.1128/JVI.75.21.10431-10445.2001. PMC114617 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [243].Davis NL, Fuller FJ, Dougherty WG, et al. A single nucleotide change in the E2 glycoprotein gene of Sindbis virus affects penetration rate in cell culture and virulence in neonatal mice. Proc Natl Acad Sci U S A. 1986;83(18):6771–6775. doi: 10.1073/pnas.83.18.6771. PMC386591 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [244].Polo JM, Johnston RE. Attenuating mutations in glycoproteins E1 and E2 of Sindbis virus produce a highly attenuated strain when combined in vitro. J Virol. 1990;64(9):4438–4444. doi: 10.1128/jvi.64.9.4438-4444.1990. PMC247913 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [245].Gidwitz S, Polo JM, Davis NL, et al. Differences in virion stability among Sindbis virus pathogenesis mutants. Virus Res. 1988;10(2–3):225–239. doi: 10.1016/0168-1702(88)90018-4 [DOI] [PubMed] [Google Scholar]
- [246].Bear JS, Byrnes AP, Griffin DE. Heparin-binding and patterns of virulence for two recombinant strains of Sindbis virus. Virology. 2006;347(1):183–190. doi: 10.1016/j.virol.2005.11.034 [DOI] [PubMed] [Google Scholar]
- [247].Byrnes AP, Griffin DE. Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation. J Virol. 2000;74(2):644–651. doi: 10.1128/JVI.74.2.644-651.2000. PMC111583 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [248].Knight RL, Schultz KLW, Kent RJ, et al. Role of N-linked glycosylation for Sindbis virus infection and replication in vertebrate and invertebrate systems. J Virol. 2009;83(11):5640–5647. doi: 10.1128/JVI.02427-08. PMC2681937 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [249].Kobiler D, Rice CM, Brodie C, et al. A single nucleotide change in the 5’ noncoding region of Sindbis virus confers neurovirulence in rats. J Virol. 1999;73(12):10440–10446. doi: 10.1128/JVI.73.12.10440-10446.1999. PMC113099 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [250].Noval MG, Rodriguez-Rodriguez BA, Rangel MV, et al. Evolution-driven attenuation of alphaviruses highlights key glycoprotein determinants regulating viral infectivity and dissemination. Cell Rep. 2019;28(2):460–471.e5. doi: 10.1016/j.celrep.2019.06.022. PMC7141928 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [251].Tucker PC, Griffin DE. Mechanism of altered Sindbis virus neurovirulence associated with a single-amino-acid change in the E2 glycoprotein. J Virol. 1991;65(3):1551–1557. doi: 10.1128/jvi.65.3.1551-1557.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [252].Lu YE, Cassese T, Kielian M. The cholesterol requirement for Sindbis virus entry and exit and characterization of a spike protein region involved in cholesterol dependence. J Virol. 1999;73(5):4272–4278. doi: 10.1128/JVI.73.5.4272-4278.1999. PMC104207 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [253].Kuhn RJ, Griffin DE, Zhang H, et al. Attenuation of Sindbis virus neurovirulence by using defined mutations in nontranslated regions of the genome RNA. J Virol. 1992;66(12):7121–7127. doi: 10.1128/jvi.66.12.7121-7127.1992. PMC240395 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [254].Hyde JL, Gardner CL, Kimura T, et al. A viral RNA structural element alters host recognition of nonself RNA. Science. 2014;343(6172):783–787. doi: 10.1126/science.1248465. PMC4209899 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [255].Frolov I, Schlesinger S. Translation of Sindbis virus mRNA: analysis of sequences downstream of the initiating AUG codon that enhance translation. J Virol. 1996;70(2):1182–1190. doi: 10.1128/jvi.70.2.1182-1190.1996. PMC189927 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [256].Toribio R, Díaz-López I, Boskovic J, et al. An RNA trapping mechanism in alphavirus mRNA promotes ribosome stalling and translation initiation. Nucleic Acids Res. 2016;44(9):4368–4380. doi: 10.1093/nar/gkw172. PMC4872096 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [257].Sanz MA, González Almela E, Carrasco L. Translation of Sindbis subgenomic mRNA is independent of eIF2, eIF2A and eIF2D. Sci Rep. 2017;7(1):43876. doi: 10.1038/srep43876. PMC5327398 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [258].Kuhn RJ, Hong Z, Strauss JH. Mutagenesis of the 3’ nontranslated region of Sindbis virus RNA. J Virol. 1990;64(4):1465–1476. doi: 10.1128/jvi.64.4.1465-1476.1990. PMC249280 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [259].Sanz MA, Carrasco L. Rna viruses and host translation machinery: a battle for control. Prog Mol Biol Transl Sci. 2011;111:163–188. [Google Scholar]
- [260].Trobaugh DW, Gardner CL, Sun C, et al. Rna viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature. 2014;506(7487):245–248. doi: 10.1038/nature12869. PMC4349380 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [261].Sokoloski KJ, Haist KC, Morrison TE, et al. Noncapped alphavirus genomic RNAs and their role during infection. J Virol. 2015;89(11):6080–6092. doi: 10.1128/JVI.00553-15. PMC4442418 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [262].LaPointe AT, Moreno-Contreras J, Sokoloski KJ. Increasing the capping efficiency of the Sindbis virus nsP1 protein negatively affects viral infection. MBio. 2018;9(6). doi: 10.1128/mBio.02342-18. PMC6299483 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [263].Cross RK. Identification of a unique guanine-7-methyltransferase in Semliki Forest virus (SFV) infected cell extracts. Virology. 1983;130(2):452–463. doi: 10.1016/0042-6822(83)90099-5 [DOI] [PubMed] [Google Scholar]
- [264].Mi S, Stollar V. Expression of Sindbis virus nsP1 and methyltransferase activity in Escherichia coli. Virology. 1991;184(1):423–427. doi: 10.1016/0042-6822(91)90862-6 [DOI] [PubMed] [Google Scholar]
- [265].Scheidel LM, Stollar V. Mutations that confer resistance to mycophenolic acid and ribavirin on Sindbis virus map to the nonstructural protein nsP1. Virology. 1991;181(2):490–499. doi: 10.1016/0042-6822(91)90881-B [DOI] [PubMed] [Google Scholar]
- [266].Scheidel LM, Durbin RK, Stollar V. Svlm21, a Sindbis virus mutant resistant to methionine deprivation, encodes an altered methyltransferase. Virology. 1989;173(2):408–414. doi: 10.1016/0042-6822(89)90553-9 [DOI] [PubMed] [Google Scholar]
- [267].Li C, Guillen J, Rabah N, et al. mRNA capping by Venezuelan equine encephalitis virus nsP1: functional characterization and implications for antiviral research. J Virol. 2015;89(16):8292–8303. doi: 10.1128/JVI.00599-15. PMC4524220 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [268].Karki D, LaPointe AT, Isom C, et al. Mechanistic insights into Sindbis virus infection: noncapped genomic RNAs enhance the translation of capped genomic RNAs to promote viral infectivity. Nucleic Acids Res. 2025;53(1). doi: 10.1093/nar/gkae1230. PMC11724270 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [269].Heise MT, Simpson DA, Johnston RE. A single amino acid change in nsP1 attenuates neurovirulence of the Sindbis-group alphavirus S.A.AR86. J Virol. 2000;74(9):4207–4213. doi: 10.1128/JVI.74.9.4207-4213.2000. PMC111935 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [270].Cruz CC, Suthar MS, Montgomery SA, et al. Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein. Virology. 2010;399(1):1–10. doi: 10.1016/j.virol.2009.12.031. PMC2830325 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [271].Zhu W-Y, Yang Y, Fu S-H, et al. Substitutions of 169Lys and 173Thr in nonstructural protein 1 influence the infectivity and pathogenicity of XJ-160 virus. Arch Virol. 2009;154(2):245–253. doi: 10.1007/s00705-008-0298-0 [DOI] [PubMed] [Google Scholar]
- [272].Akhrymuk I, Kulemzin SV, Frolova EI. Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II. J Virol. 2012;86(13):7180–7191. doi: 10.1128/JVI.00541-12. PMC3416352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [273].Frolova EI, Fayzulin RZ, Cook SH, et al. Roles of nonstructural protein nsP2 and alpha/beta interferons in determining the outcome of Sindbis virus infection. J Virol. 2002;76(22):11254–11264. doi: 10.1128/JVI.76.22.11254-11264.2002. PMC136776 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [274].Zhu WY, Fu SH, Wang JL, et al. Effects of the nsP2-726 pro mutation on infectivity and pathogenesis of Sindbis virus derived from a full-length infectious cDNA clone. Virus Res. 2009;142(1–2):204–207. doi: 10.1016/j.virusres.2009.01.017 [DOI] [PubMed] [Google Scholar]
- [275].Park E, Griffin DE. The nsp3 macro domain is important for Sindbis virus replication in neurons and neurovirulence in mice. Virology. 2009;388(2):305–314. doi: 10.1016/j.virol.2009.03.031. PMC2683903 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [276].Abraham R, McPherson RL, Dasovich M, et al. Both ADP-ribosyl-binding and hydrolase activities of the alphavirus nsP3 macrodomain affect neurovirulence in mice. MBio. 2020;11(1). doi: 10.1128/mBio.03253-19. PMC7018654 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [277].Landers VD, Wilkey DW, Merchant ML, et al. The alphaviral capsid protein inhibits IRAK1-dependent TLR signaling. Viruses. 2021;13(3):377. doi: 10.3390/v13030377. PMC7997285 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [278].Landers VD, Thomas M, Isom CM, et al. Capsid protein mediated evasion of IRAK1-dependent signalling is essential to Sindbis virus neuroinvasion and virulence in mice. Emerg Microbes Infect. 2024;13(1):2300452. doi: 10.1080/22221751.2023.2300452. PMC10773654 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [279].Sokoloski KJ, Nease LM, May NA, et al. Identification of interactions between Sindbis virus capsid protein and cytoplasmic vRNA as novel virulence determinants. PLoS Pathog. 2017;13(6):e1006473. doi: 10.1371/journal.ppat.1006473. PMC5507600 [DOI] [PMC free article] [PubMed] [Google Scholar]
- [280].Adams AP, Aronson JF, Tardif SD, et al. Common marmosets (Callithrix jacchus) as a nonhuman primate model to assess the virulence of eastern equine encephalitis virus strains. J Virol. 2008;82(18):9035–9042. doi: 10.1128/JVI.00674-08. PMC2546911 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The authors confirm that the data supporting the findings of this study are available within the article, and that there is no new primary data associated with this research.
